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ABSTRACT: ~-lactamases are a group of enzymes that confer resistance to penam and 
cephem antibiotics by hydrolysis of the ~-lactam ring, thereby inactivating the antibiotic. 
Crystallographic and computer modeling studies of RTEM-1 ~-lactamase have indicated 
that Asp 132, a strictly conserved residue among the class A ~-lactamases, appears to be 
involved in substrate binding, catalysis, or both. To study the contribution of residue 132 
to (3-lactamase function, site saturation mutagenesis was used to generate mutants coding 
for all 20 amino acids at position 132. Phenotypic screening of all mutants indicated that 
position 132 is very sensitive to amino acid changes, with only N132C, N132D, N132E, 
and N132Q showing any appreciable activity. Kinetic analysis of three of these mutants 
showed increases in KM, along with substantial decreases in kcat· Efforts to trap a stable 
acyl-enzyme intermediate were unsuccessfuL These results indicate that residue 132 is 
involved in substrate binding, as well as catalysis, and supports the involvement of this 
residue in acylation as suggested by Strynadk:a et al. 
Crystallographic and computer modeling studies of RTEM-1 ~-lactamase have 
indicated that Lys 73 and Glu 166, two strictly conserved residues among the class A ~­
lactamases, appear to be involved in substrate binding, catalysis, or both. To study the 
contribution of these residues to ~-lactamase function, site saturation mutagenesis was used 
to generate mutants coding for all 20 amino acids at positions 73 and 166. Then all 400 
possible combinations of mutants were created by combinatorial mutagenesis. The colonies 
harboring the mutants were screened for growth in the presence of ampicillin. The 
competent colonys' DNA were sequenced, and kinetic parameters investigated. It was 
found that lysine is essential at position 73, and that position 166 only tolerated fairly 
conservative changes (Aspartic acid, Histidine, and Tyrosine). These functional mutants 
exhibited decreased kcat's, but KM was close to wild-type levels. The results of the 
combinatorial mutagenesis experiments indicate that Lysis absolutely required for activity 
at position 73; no mutation at residue 166 can compensate for loss of the long side chain 
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amine. The active mutants found--K73K/E166D, K73KIE166H, and K73KIE166Y were 
studied by kinetic analysis. These results reaffirmed the function of residue 166 as 
important in catalysis, specifically deacylation. 
The identity of the residue responsible for enhancing the active site serine (Ser 70) in 
RTEM-1 ~-lactamase has been disputed for some time. Recently, analysis of a crystal 
structure of RTEM-1 ~-lactamase with covalently bound intermediate was published, and it 
was suggested that Lys 73, a strictly conserved residue among the class A ~-lactamases, 
was acting as a general base, activating Ser 70. For this to be possible, the pKa of Lys 73 
would have to be depressed significantly. In an attempt to assay the pKa of Lys 73, the 
mutation K73e was made. This mutant protein can be reacted with 2-bromoethylamine, 
and activity is restored to near wild type levels. 15N-2-bromoethylamine hydrobromide and 
13e-2-bromoethylamine hydrobromide were synthesized. Reacting these compounds with 
the K73e mutant gives stable isotopic enrichment at residue 73 in the form of 
aminoethylcysteine, a lysine homologue. The pKa of an amine can be determined by NMR 
titration, following the change in chemical shift of either the 15N-amine nuclei or adjacent 
Be nuclei as pH is changed. Unfortunately, low protein solubility, along with probable 
label scrambling in the Be experiment, did not permit direct observation of either the 15N 
or Be signals. Indirect detection experiments were used to observe the protons bonded 
directly to the 13e atoms. Two NMR signals were seen, and their chemical shift change 
with pH variation was noted. The peak which was determined to correspond to the 
aminoethylcysteine residue shifted from 3.2 ppm down to 2.8 ppm over a pH range of 6.6 
to 12.5. The pKa of the amine at position 73 was determined to be -10. This indicates that 
residue 73 does not function as a general base in the acylation step of the reaction. 
However the experimental measurement takes place in the absence of substrate. Since the 
enzyme undergoes conformational changes upon substrate binding, the measured pKa of 
the free enzyme may not correspond to the pKa of the enzyme substrate complex. 
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Nomenclature and Abbreviations 
Mutants are specified as Asn132Gly or N132G; asparagine at position 132 has been 
changed to glycine. The one-letter codes are: alanine, A; arginine, R; asparagine, N; 
aspartate, D; cysteine, C; glutamate, E; glutamine, Q; glycine, G; histidine, H; isoleucine, I; 
leucine, L; lysine, K; methionine, M; phenylalanine, F; proline, P; serine, S; threonine, T; 
tryptophan, W; tyrosine, Y; valine, V. Bromoethylamine is abbreviated BEA, and 
aminoethylcysteine is AEC. Polyacrylamide gel electrophoresis is PAGE. All remaining 
abbreviations are described where applicable. 
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Chapter 1 
Introduction to Aspects of Protein Chemistry and 13-lactamase 
2 
INTRODUCTION 
Of the three main classes of biological molecules, nucleic acids, fatty acids and 
proteins, proteins exhibit the widest range of structures and functions (1). Proteins and 
peptides are polyamides composed of a-amino acids, and most proteins are only made up 
from a pool of the twenty so called "natural" amino acids. Amino acids are molecules 
containing an amino group, a carboxylic acid group, and another group (R) which 
determines the identity of the amino acid. All of the naturally occurring amino acids are 
chiral (except glycine, in which R=hydrogen), and of the two possible enantiomers, only 
the L-enantiomer is found in most peptides and proteins. The R groups can be classified 
into two main arrays--polar and non-polar. Most of the nonpolar amino acids have R 
groups that are hydrocarbon in nature, and can be important in hydrophobic interactions. 
Many of the polar R groups have ionizable R groups (or side chains), are involved in a 
variety of interactions, and can function in catalysis (Figure 1). 
Linking a-amino acids together, the amino group of one condensing with the 
carboxylate of another, gives an amide called a peptide (Figure 2), with larger peptides 
considered proteins. The lone pair of the nitrogen is in conjugation with the carbonyl 
double bond as shown in Figure 3, which gives the C-N bond partial double bond 
character. It is energetically favorable for each of the atoms attached to the C-N bond to be 
in the same plane and thus the barrier to rotation is rather high (-80 kJ mol-1)(2). It follows 
that there is not free rotation in the peptide chain about NH-CO bonds. 
The typical charge separation in a peptide bond is shown in Figure 3. Contrary to 
predictions from resonance structures, the nitrogen has a negative rather than a positive 
charge. The charge separation gives each amino acid an associated dipole which interacts 
with neighboring dipoles (3). The peptide backbone is therefore quite polar and particularly 
available for hydrogen bonding (Figure 3), since the amide protons will readily interact 




arginine )l ~COOH 12.5 H2N N • 
' H NH2 
aspartic acid ---xCOOH 3.9 HOOC 
.... 
H NH2 
cysteine ~COOH 9.3 HS ... 
H NH2 
glutamic acid HOOC~COOH 4 .3 
H NH2 
histidine ~COOH 6.1 
H NH 2 
lysine H2N~COOH 10.5 
H NH2 
DACOOH tyrosine 9.1 
NH2 
HO 
serine ~COOH HO ... >13 
H NH2 
Figure 1. Name, structure, and pKa of amino acids with ionizable side chains. 
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Typical charges on atoms of the peptide bond 
Conjugation in peptide bonds. Effective overlap between the nitrogen lone pair 
and the carbonyl group requires coplanarity of the p-orbitals of N,C, and 0. 
8- I 
O=C ,. I 
N-H--0-=-=C ~+ 
I ,. u N-H 
I 
Hydrogen bonding between peptide bonds 
Figure 3. Some features of the peptide bond. 
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amines because the lone pair on nitrogen is conjugated (Figure 3) with the carbonyl and 
hence not readily available for donation to electrophiles. Peptides are therefore difficult to 
alkylate or acylate and are only weakly basic (4). 
The linear sequence of amino acids is known as the primary structure of a protein. 
Protein chains are coiled or folded in an ordered way dependent upon a number of 
interactions including maximization of hydrogen bonding between amino acid residues, 
hydrophobic effects and other forces (5). The primary sequence often folds into discrete 
organized elements of structure called secondary structure. These include a.-helices, [3-
sheets, and [3-turns (Figure 4). Secondary structural elements often comprise important 
domains of proteins. The overall structure, often a combination of secondary structural 
elements along with sections of random coil, is known as the tertiary structure or overall 
fold. Many proteins also exist as multimers of identical or mixed protein subunits, and this 
multimeric arrangement is called quaternary structure. 
The most abundant conformation in proteins is an ordered coil known as the a.-
helix. The a.-helix (Figure 4) is right-handed, and the bulky side-chains project outwards 
from the helix, thus experiencing little steric hindrance. The helix has 3.6 residues per turn 
and the backbone NH of each amino acid residue hydrogen bonds to the carbonyl of the 
fourth residue towards theN-terminal end. The ~-pleated sheet is a conformation in which 
protein chains align themselves side-by-side (Figure 4). The alignment may be either 
parallel, with all N-terminal groups at the same end, or anti-parallel, with N-terminal ends 
close to the C-terminal ends of neighboring chains. In either case, the chains are organized 
by hydrogen bonding and the flat peptide regions alternate between two directions to give a 
pleated shape. In small peptides a parallel sheet is only feasible intermolecularly, but an 
intramolecular antiparallel [3-sheet structure becomes likely if a peptide chain undergoes a 
hairpin bend. The most common type of hairpin bend is call the ~-turn (Figure 4). There is 
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Figure 4. Hydrogen bonding interaction dary structures. . s in protein secon 
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steric crowding in the region of the tum which restricts the type of amino acid which may 
be present. Glycine, proline, and D-amino acids are favored in these positions. 
The structures of many globular proteins have been determined by X-ray 
crystallography or by NMR spectroscopy in solution (6). The forces which maintain a 
protein's conformation are non-covalent interactions (except for disulfide linkages). Polar 
groups often occur near other polar groups or on the surface of the protein while nonpolar 
groups cluster together, usually near the center of the molecule. Other non-amino acid 
components are regularly seen in proteins, especially carbohydrates, metals, and small 
organic molecules called co-factors. The latter two cofactors are frequently seen in 
enzymes. 
Enzymes are proteins that catalyze reactions in biological systems. The first enzyme 
to be recognized as a protein was jack bean urease (7), which catalyzes the hydrolysis of 
urea to C02 and NH3. Enzymes can have molecular weights of several thousand to several 
million, yet can catalyze reactions on molecules as small as N2 and C02. There are a wide 
variety of rationalizations for enzyme catalysis. According to Kraut (8), modem theories of 
enzyme catalysis can be traced to Haldane (9), who introduced the concept that an enzyme-
substrate complex requires additional activation energy prior to reaction. Transition-state 
theory was then developed by Erying (10); this is the basis for the hypothesis of Pauling 
(11) whose vision of an enzyme was a flexible template designed by evolution to be 
complementary to the structure of a substrate at the transition state of the reaction rather 
than at the ground state. As the reaction proceeds toward the transition state, the enzyme 
interacts more effectively with the transition state geometry and electronic environment 
(increased binding energy), which consequently accelerates the reaction. This phenomenon 
is referred to as transition-state stabilization. 
The substrate in an enzyme catalyzed reaction only binds to a small area of the 
enzyme referred to as the active site of the enzyme. The interactions between enzyme and 
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substrate must be quite specific in order to attain a rate increase. It has been suggested (12) 
that the large binding energies between substrate and enzyme result from close packing of 
atoms within the protein. and that the large size may be required to achieve this. Therefore, 
the entire protein outside of the active site may be functioning as a scaffold to hold the 
active site in the proper geometry for catalysis. 
The two key features of enzyme catalysis are specificity and rate acceleration. The 
active site contains elements responsible for both of these properties, and these features are 
not necessarily distinguishable. Specificity refers to both specificity of binding and 
specificity of reaction. Enzyme catalysis begins with an interaction between the substrate 
and the enzyme known as the ES, or Michaelis complex. The binding specificity is 
conferred by certain active site constituents which are involved in binding interactions with 
the substrate. These interactions include covalent, electrostatic, ion-dipole, dipole-dipole, 
hydrogen-bonding. charge-transfer, hydrophobic. hydrophilic, and van der Waals 
interactions. Binding specificity can be absolute, where only one substrate forms an ES 
complex with a particular enzyme that leads to product formation. Or binding specificity 
can be very broad. in which case many molecules of related structure can be bound and 
processed by the enzyme. 
Reaction specificity arises from other constituents of the active site, namely, 
specific acid base, and nucleophilic functional group of amino acids and specific 
coenzymes or cofactors. In general, catalysts stabilize the transition-state energy relative to 
the ground state, and this decrease in .::\G+ is responsible for the resulting rate acceleration 
(Figure 5). An enzyme has various ways of inducing catalysis; by destabilization of the ES 
complex, by stabilization of the transition states, by destabilization of intermediates, and 
during product release. Consequently, multiple steps, each having small .::\G+ values, may 
be involved. As a result of these multiple catalytic steps, rate accelerations of 1QIO over the 
___ __...... _,/ 











1-4------6.G of activation 
~atalyzed 
I6.G of reaction ' E + p --
Reaction coordinate 
Figure 5. Reaction coordinate diagram for an enzyme catalyzed reaction. From 
"Biochemistry, A Problems Approach," Wood, W.B. et al., Benjamin/Cummings, Menlo 
Park, 1981. 
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corresponding non-enzymatic reactions are possible. Catalysis in general, however, does 
not alter the equilibrium of a reversible reaction. 
The number of molecules of substrate converted to product per unit time per 
molecule of enzyme active site is the turnover number. Triose phosphate isomerase is one 
of the most efficient enzymes (13), having a turnover number of 3500 sec-1. As there are 
two other important steps to enzyme catalysis, namely substrate binding and product 
release, high turnover numbers are only useful if these two steps occur at faster rates. This 
is not always the case. 
Once substrate binds to the active site of the enzyme, there are various tools that 
enzymes utilize to catalyze the conversion of substrate to product (14-16). Some of the 
most common mechanisms are approximation, general acid-base catalysis, covalent 
catalysis, and electrostatic catalysis. In approximation, the enzyme binds the substrate close 
to the reaction center, resulting in a loss of rotational and translational entropies of the 
substrate. Because the catalytic groups and substrate are now part of the same molecule, the 
reaction becomes first order rather than second order, and the concentration of the reacting 
groups is essentially increased. This phenomenon can be illustrated with non enzymatic 
model studies such as the second-order reaction of acetate with an aryl acetate (Figure 6). If 
the rate constant k for this reaction is set equal to 1.0 M-1sec-1, then the effect of decreasing 
the rotational and translational entropy is determined by measuring the corresponding first-
order rate constants for related intramolecular reactions. Figure 7 illustrates that holding 
reacting groups in close proximity increases the reaction rate ( 17, 18). 
While first and second-order rate constants cannot be directly compared, the 
efficiency of an intramolecular reaction can be defined by effective molarity (EM), which is 
the concentration of the moiety required to cause the intermolecular reaction to proceed at 





Figure 6. Second-order reaction of acetate with aryl acetate 
R~~laDl~ ~ R~lali~ ra~. k. Eff~liY~ Molari~ 
0 
A oAr 




~OM 7.39 X 10-S S-1 220 s-1 220M o-
0 
0 
¢OM 1.71 X 10-2 S-1 
o-
5.1 x 104 s-1 5.1 X 104 M 
0 
0 
¢~M 7.61 X 10-1 S-1 2.3 x 106 s-1 2.3 X 106 M 
0 
0 0 
~OM 3.93 s-1 1.2 x 107 s-1 1.2 X 107 M 
Figure 7. Effect of Approximation on Reaction Rates (13,14) 
13 
order rate constant for the intramolecular reaction by the second-order rate constant for the 
corresponding intermolecular reaction (Figure 7). This indicates that acetate ion would have 
to be a concentration of 220 M in order for the intermolecular reaction to proceed at a rate 
comparable to that of the glutarate monoester reaction. Thus the effect of decreasing the 
entropy is significant. Effective molarities for a wide range of intramolecular reactions have 
been measured (18), and the efficiency of intramolecular catalysis can be as high as 1Ql6 M 
for relative systems. Thus, holding groups near to one another in an enzyme-substrate 
complex can be an important contributor to catalysis. 
In any reaction where proton transfer occurs, general acid catalysis and or general 
base catalysis is effective. Unlike reactions in solution, an enzyme can utilize acid and base 
catalysis simultaneously (Figure 8). It is important to appreciate the fact that the pKa values 
of amino acid side-chain groups within the active site of enzymes are not necessarily the 
same as those measured in solution ( 19). The simultaneous donation of a proton to a 
carbonyl and removal of an a-proton could account for the ability of an enzyme to 
deprotonate relatively high pKa carbon acids and make the corresponding enols (20). 
Therefore, removal of seeming higher pKa protons from substrate by active site bases may 
not be as unreasonable as would appear if only solution chemistry were taken into 
consideration. 
The enzyme a-chymotrypsin, a serine protease, can illustrate general acid-base 
catalysis (21). It utilizes as active site serine residue in the catalytic cleavage of peptide 
bonds. A serine hydroxyl would normally be a poor nucleophile. However, aspartic acid 
and histidine residues nearby have been implicated in the microscopic conversion of the 
serine to an alkoxide by a mechanism call the charge relay system (Figure 9). This catalytic 
triad involves the aspartate carboxyl interacting with the histidine imidazole which, in tum, 




Nucleophillic catalysis in an enzyme. 
Electrostatic stabilization of the transition state in an active site. 
Simultaneous acid and base catalysis in an enzyme active site. 
Figure 8. Examples of catalysis in an enzme active site. 
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Figure 9. Charge relay system for activation of an active site serine residue. 
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this would be expected to be a high-energy process; presumably the pKa values at the active 
site are different from those in solution. 
Some enzymes can use nucleophilic amino acid side chains in the active site to form 
covalent bonds with the substrate. A second substrate can then react with this enzyme-
substrate intermediate to generate product (Figure 8). The most common active site 
nucleophiles are the thiol group of cysteine, the hydroxyl group of serine, the imidazole of 
histidine, the amino group of lysine, and the carboxyl groups of aspartate and glutamate. 
These nucleophilic groups are activated by deprotonation, often by a neighboring base, or 
by a water molecule which is deprotonated in a general base reaction. If the substrate in an 
enzyme catalyzed reaction were a peptide, nucleophilic catalysis using a serine hydroxyl 
would yield an ester intermediate which is much more subject to hydrolysis than the 
starting amide. This is the mechanism followed by the serine proteases (22). The greatest 
catalytic advantage in using an active site residue instead of water directly is that the former 
is a unimolecular reaction (since the substrate is bound to the enzyme, attack by the serine 
residue is equivalent to an intramolecular reaction), which is entropically favored over the 
bimolecular reaction with water. Also, alkoxides and thiolates are better nucleophiles than 
hydroxide (23). 
Electrostatic interactions many not be as obvious as shown in Figure 8. Instead of a 
full positive charge in the enzyme there may be one or more local dipoles having partial 
positive charges directed at the forming transition state anion. In the case of the serine 
protease subtilisin it has been suggested that the lowering of the free energy of the activated 
complex is due largely to hydrogen bonding of the developing oxyanion with protein 
residues. When the suspected active site proton donor was replaced by a leucine residue 
using site-directed mutagenesis techniques, the kcat greatly diminished, but the Km 
remained the same, indicating the importance of the hydrogen bonding to catalysis (24). 
Furthermore, a mutant of subtilisin in which all three of the catalytic triad residues (Ser 
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221, His 64, Asp 32) were replaced by alanine residues was still able to hydrolyze am ides 
103 times faster than the uncatalyzed hydrolysis rate (albeit 2 x 106 time slower than the 
wild-type enzyme)(25). This suggest that factors other than nucleophilic and general base 
catalysis must be important. Sophisticated free energy calculation of serine protease active 
sites indicated that the primary mechanism for rate acceleration is derived from electrostatic 
stabilization in the transition state (26). 
13-LACTAMASE 
In 1929, Alexander Fleming discovered the existence of a compound produced by 
certain fungi that inhibited the growth of bacteria in media on which the fungi were 
growing (27). Penicillin and the other related penam and cephem antibiotics (Figure 10) 
have since been shown to block bacterial cell wall biosynthesis by inhibiting the 
crosslinking of cell wall peptidoglycans by the 0-Ala-o-Ala carboxypeptidases and 
transferases (28). The oo-carboxypeptidase/transpeptidases (29) comprise a class of low-
molecular weight penicillin binding proteins characterized by their ability to catalyze acyl 
transfer reactions from 0-alanyl-o-alanine-terminated peptides and depsipeptide analogs 
(Figure 11). These enzymes are responsible for crosslinking the peptidoglycan bacterial cell 
wall, and involve a covalent acyl-enzyme intermediate with the C-1 0-alanine residue and 
an active site serine (30). This intermediate can be attacked by thee-amino group of a lysine 
residue from an adjacent peptide strand of the peptidoglycan, which results in the stabilized 
crosslinked structure, or hydrolyzed by a water molecule, which results in overall removal 
of one o-alanine residue. Additionally, then-terminus of another peptide can attack, giving 
another crosslinked structure. 
In addition to the usual D-alanyl peptide substrates, 13-lactam antibiotics also interact 
with the carboxypeptidases. The 13-lactam antibiotics, however, are inhibitors. Since the 
carboxyl and amino portions of the 13-lactam antibiotic are still attached following the initial 
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benzyl penicillin cephalothin 
Figure 10. Representative ~-lactam antibiotics. Benzyl penicillin is a member 
of the penam family, cephalothin is a cephem. Arrow points to bond 
broken during hydrolysis. 
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Peptidoglycan JVVV' D-Ala -D-Ala-OH 
Peptidoglycan-'V'VV"D-Ala (Enzyme) + D-Ala-OH 
H2N-Gly .J'VVV' Peptidoglycan 




(Carboxypeptidase) ( Transpeptidase) 
Figure 11. The process of bacterial cell wall biosynthesis. The strands of peptidoglycan 
are targeted by the D,D-carboxypeptidase, resulting in the hydrolysis of the terminal 
D-alanine residue. The acyl-enzyme intermediate can then be deacylated by water or an 
amino acceptor, the latter resulting in a stabilized crosslinked structure. 
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hydrolysis reaction, water or another peptide is prevented from entering the active site, and 
hydrolysis of the acyl-enzyme intermediate is blocked, thus inhibiting the enzyme (Figure 
12). This prevents the crosslinking of the cell wall peptidoglycans and results in the 
eventual lysis of the cell. Tipper and Strominger initially proposed that the J3-lactam 
antibiotics function as structural analogs to the D-ala-D-ala dipeptide (31), and thereby 
"fool" the enzyme into binding the antibiotic (Figure 13). They were successful in proving 
this hypothesis by pulse-chase experiments (32). 
In 1940, Abraham and Chain discovered that extracts from certain bacteria would 
neutralize the antibiotic effect of penicillin (33). These extracts were shown to contain a 
variety of enzymes capable of hydrolyzing the J3-lactam ring of penicillin, yet were not 
inactivated in the process, as were the PBP's (Penicillin Binding Proteins)(Figure 14). 
These enzymes came to be known as J3-lactamases. The resistance to J3-lactam antibiotics in 
many species of bacteria is due to the wide spread of genes encoding J3-lactamases. It has 
been proposed that the origin of these genes lies with the penicillin-sensitive D-alanyl-D-
alanyl peptidases (34). Huletsky has made significant progress toward answering the 
question of how the class A J3-lactamases have evolved by studying the phylogeny of the 
SHV-2 J3-lactamase (35). 
Over 80 J3-lactmases have been identified, and are divided into three categories 
based on size, sequence homology, and activity (36). The class A J3-lactamases include the 
RTEM J3-lactamases (RTEM-1, 2 and 3) of Escherichia coli (37), Staphylococcus aureus 
PCl (38), Bacillus licheniformis 749/C (39), and Bacillus cereus 569/HI (40). All of these 
enzymes have a molecular weight of around 30 kilodaltons and exhibit considerable 
sequence homology (-30%). There are only two class B J3-lactamases, those of B. cereus 
and Proteus maltophilia (41). The class B J3-lactamases are smaller (molecular weights of 
approximately 23 kD) and form metalloenzyme complexes with zinc. The class C J3-
lactamases are the largest at 40 kD and include Enterbacterium cloacae P99 and Escherichia 
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Figure 13. Chemical structures emphasizing the close structural analogy of the 
13-lactam antibiotcs (right) with the D-Ala-D-Ala dipeptide (left). Hydrolysis of 











Figure 14. Interaction of the ~-lactamases with ~-lactam antibiotics results in an 
acyl-enzyme intermediate which is rapidly hydrolyzed by a bound water molecule. 
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coli K12 (42). In addition to size, the three classes also differ in substrate specificity. The 
class A ~-lactamases preferentially hydrolyze penams, while the other two classes prefer 
cephem antibiotics. 
Analysis of the primary sequences of class A ~-lactamases indicated a number of 
conserved residues (Figure 15). The active site serine, Ser 70 (Ambler numbering, 36) is 
conserved, along with other residues such as Glu 166, Lys 73, and the so called SON loop 
(Ser 130, Asp 131, Asn 132). With the publication of a crystal structure of a class A~­
lactamase, that of Staphylococcus aureus PC1, the location of many of these conserved 
residues in the active site was confirmed (Figure 16)(43). The structure displays a two-
domain structural motif, with one domain consisting solely of a-helices, and the second 
domain having a mixed structure, containing a minimum five-stranded ~-sheet sandwiched 
between two sets of a-helices. The active site is defined by the interface between the two 
domains, bordered on one side by the ~-7 strand and on the other by the a-2 and a-10 
helices, with the active site serine residing at the amino-terminal end of the a-2 helix, in the 
bottom of the active site cleft. 
RTEM-1 ~-lactamase is a 28.5k.D soluble protein isolated from E. coli. It differs 
from RTEM-2 ~-lactamases by one residue (residue 39) and from RTEM-3 by three 
residues (residues 39, 104, and 238)(44). Like the other class A ~-lactamases, RTEM 
preferentially hydrolyzes penam antibiotics over cephems (Figure 10). The rate of penam 
hydrolysis approaches diffusion control limits, with a second-order rate constant on the 
order of 108 M-ls-1(13). The ~-lactam substrate is subjected to nucleophilic attack on the 
lactam carbonyl group by the active site serine (Ser 70 in RTEM). Nucleophilic attack 
proceeds through a tetrahedral intermediate which is proposed to be stabilized by an 
oxyanion hole (43), similar to that observed in the serine proteases (45). The resulting acyl-
enzyme intermediate is rapidly hydrolyzed by a bound water, which is activated by Glu 166 
(46), leading to an inactive antibiotic (Figure 17). 
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Figure 15. Sequence alignment of Class A ~-lactamases. the sequences are: (a) 
Staphylococcus aureus PC1; (b) Bacillus licheniformis 749/C; (c) Bacillus cereus 569/H 
lactamase 1; (d) Escherichia coli pBR322 RTEM-1. Numbering starts from then-terminus 
of the longest form of the B. licheniformis enzyme that has been isolated, and takes into 
account the gaps postulated in the currently known sequences to obtain optimal matching. 
the vertical bars show the n-termini of naturally released enzymatically active molecules. 
Residues that are identical in all four molecules are shown in capitals (1). 
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Figure 17. Detailed mechanism postulated for 13-lactam hydrolysis catalyzed 
by 13-lactamase. 
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Much research has been performed in our laboratory to investigate the roles of 
several important residues in RTEM-1 13-lactamase including site-saturation of residues Thr 
71(47), Lys 73 (48), Glu 166 (49), Lys (50), Ala 237 (51), Ser 130 (52), and residues 
237-240 (53). Other research has been directed towards the generation of mutants at Ser 70 
(54, 55). In spite of the wealth of information concerning catalysis in RTEM-1 13-lactamase, 
questions still persist. This thesis concerns some of the remaining puzzles in the RTEM-1 
active site. The function of Asn 132, a strictly conserved residue among the class A f3-
lactamases was not known. Similarly, the details of residues 73 and 166, and any possible 
interactions was yet investigated. And finally, the nature of activation of the active site 
serine nucleophile was unknown. 
Site directed mutagenesis has been shown to be an effective tool for the study of 
enzyme structure/function relationships (56). To further investigate the structural 
requirements for catalysis in RTEM-1 13-lactamase, new mutants have been generated, and 
some existing mutants have been studied using different approaches. Chapter 2 looks at the 
function of Asn 132 as studied by site-saturation mutagenesis. A technique known as 
combinatorial mutagenesis is described in Chapter 3, and is used to study interactions 
between residues 73 and 166, with 400 mutants being generated and easily screened for 
activity. Finally, the question of whether Lys 73 functions as a general base, activating Ser 
70, is investigated via sequential site-directed mutagenesis, chemical modification, and 
NMR spectroscopy. The goal of this research is to gain a better understanding of the 
structural basis for catalysis in enzyme systems. 
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Chapter 2 
Site-Satruation of Residue 132 in RTEM-1 13-lactamase 
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INTRODUCTION 
RTEM-1 ~-lactamase is one of a group of related enzymes characterized by their 
ability to confer resistance to penam and cephem antibiotics such as penicillin and 
cephalothin (l)(Figure 1). This bacterial resistance is the result of enzyme catalyzed 
hydrolysis of the ~-lactam ring, which renders the antibiotic inactive (2). The mechanism 
is proposed to involve an active site serine responsible for nucleophilic attack on the ~­
lactam ring, leading to an acyl-enzyme intermediate which is subsequently hydrolyzed by 
a bound water molecule (Figure 2). 
The ~-lactamases are classified based upon molecular weight, requirement of 
metal ions, substrate specificity, and sequence homology (3). RTEM-1 is a member of the 
class A ~-lactamases which consists of enzymes of molecular weight approximately 29 
kD, and possessing a serine as an active site nucleophile (1). Sequence homology, 
between 30 to 50%, is high among the class A enzymes. Other class A ~-lactamases 
include those from Staphylococcus aureus (PC1)(4), Bacillus licheniformus (749/C)(5), 
Bacillus cereus (569/H)(6) and Escherichia coli (RTEM-1 and RTEM-2)(7). 
RTEM-1 ~-lactamase is the enzyme encoded by the ampicillin resistance gene in 
the E. coli plasmid pBR322. It is synthesized as a 286 amino acid pre-protein, with a 23 
amino acid leader sequence cleaved during export to the periplasm, giving a molecular 
weight of the mature enzyme of 28.5 kD (8). RTEM-1 has been the subject of much study 
due to the fact that its gene is easily manipulated. This has lead to studies in protein 
excretion (9), expression of fusion proteins (1 0), and use as a selectable marker ( 11 ). Our 
laboratory has studied ~-lactamase primarily as a model enzyme for examining the 
structural basis of catalysis (12-19). 
With the publication of the crystal structure of a class A ~-lactamase, that of 
Staphylococcus aureus, it was possible to choose residues for study based on both their 




Figure 1. Representative J3-lactarn antibiotics. Amoxicillin is a member of the 















Figure 2. Overall reaction catalyzed by ~-lactarnase 
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Figure 3. Structure of RTEM-1 f3-lactamase. 
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structure of an enzyme-substrate co-crystal had been solved, model building with 
ampicillin indicated that only a few modes of binding are possible. Hertzberg et al (20) 
proposed that Lys 73 and Glu 166 were involved in the catalytic mechanism along with 
Ser 70. These residues are separated by 2.2 A and are both conserved among class A ~­
lactamases. Sequence alignments of the class A 13-lactamases showed a number of 
conserved residues, including the so called SDN loop of residues 130-132 (Ser 130, Asp 
131, Asn 132, Figure 4)(21 ). Further analysis of the crystal structure indicated that Asn 
132, was in or near the putative active site (Figure 5). 
Mutagenesis of Glu 166 showed that this residue is involved in deacylation, 
illustrated by the detection of a stable acyl-enzyme intermediate (22). One of these 
deacylation-deficient mutants, E166N, was used by Strynadka et al. to crystallize the 
acyl-enzyme intermediate (23). Analysis of this structure, the first 13-lactamase structure 
with substrate in the active site, revealed the identity of many other residues involved in 
substrate binding and/or catalysis, and suggested a catalytic mechanism (Figure 6). 
Asn 132 was proposed to be important in binding substrate and also function as a 
hydrogen bond acceptor, orienting the amine functionality of Lys 73. Since Lys 73 has 
been suggested as being the general base responsible for assisting Ser 70 in acylation, any 
residue interacting with Lys 73 should influence catalysis. Thus changes at position 132 
should affect both substrate binding and acylation. A previous study by Jacob et al. 
generated two mutations at position 132 (21). To further probe the function of residue 
132, site-saturation mutagenesis was performed, generating all 20 possible amino acids at 
position 132. Subsequent analysis of these mutants indicate that residue 132 does indeed 
participate in substrate binding and acylation 
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(a) 124-A a i t m S D N t A a N 1 1 t-136 
(b) 124-A s m t y S D N t A n N k i i-140 
(c) 124-A s 1 r y S D N a A q N 1 i 1-140 
(d) 124-A a v r s S D N t A g N 1 i f-140 
Figure 4. Amino acid sequence alignment of four class A ~-lactamases in the region of 
Asn 132 (in bold). The sequences are: (a) Escherichia coli pBR322 RTEM-1; (b) 
Staphylococcus aureus PC1; (c) Bacillus licheniformis 749/C; (d) Bacillus cereus 569/H. 
The numbering starts from then-terminus of the longest form of the B. licheniformis 
enzyme that has been isolated, and takes account of the gaps postulated in the currently 
known sequences to obtain optimal matching (1). 
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Figure 5. Arrangement of residues in the active site of RTEM-1 J3-lactamase 
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MATERIALS AND METHODS 
Enzymes and Chemicals. Enzymes were purchased from Boehringer Mannheim 
Biochemicals, New England Biolabs, and Promega. Antibiotics were from Sigma. 
Radioactive compounds were supplied by Amersham. Isopropyl-~-thiogalactoside (IPTG) 
was from International Biotechnologies Inc. (IBI). Molecular biology grade reagents 
agarose, acrylamide, phenol, chloroform, ammonium persulfate were from Bio Rad. 
Bacterial Strains. Escherichia coli were used in all experiments. Plasmid DNA 
was grown in strain HB101 (24); the pJN expression vector was grown in strain D1210, 
which is lac iQ. Culture media was L broth unless otherwise indicated. Cells were made 
competent for transformation of plasmid DNA using a process adapted from Hanahan 
(25). 
DNA. Oligonucleotides were synthesized by the Caltech Microchemical Facility 
using phosphoramidite chemistry (26) on an Applied Biosystems automated DNA 
synthesizer 380A. Degenerate oligonucleotides were made equimolar in A, C, G, and Tat 
positions 1 and 2 of the codon, and in C and G at position 3. These oligonucleotides were 
purified by preparative polyacrylamide gel electrophoresis. 
Wild-type plasmid pBR322 and bacteriophage M13 mp18 replicative form (RF) 
DNA were purchased from Bethesda Research Laboratories. Mutant plasmids and RF 
phage were purified from E. coli by alkaline lysis method (27). Single-stranded phage 
DNA was prepared from phage supernatant by precipitation with 20% polyethylene 
glycol-6000/2.5 M NaCl (28) followed by phenol/chloroform extraction and ethanol 
precipitation. 
Restriction digest typically used 10-20 ~g plasmid DNA, 2-5 units of restriction 
enzyme, and 2 ~1 lOX digest buffer in 20 ~1 at 37°C for 1-2 hours. DNA restriction 
fragments were run in 1.2% low melt agarose gels, visualized with ethidium bromide, and 
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isolated by established procedures (29). 
Oligonucleotide-directed Mutagenesis. Two new restriction endonuclease sites 
were added to facilitate cassette mutagenesis and screening. Oligonucleotide-directed 
mutagenesis (Figure 6) of the existing ~-lactamase gene in a modified pBR322 plasmid 
(30) was used to create a Sac I site at 3748 bases (Ambler numbering), and a Ksp I (Sac 
II) site at 3712. This was accomplished using the in vitro mutagenesis system ™ by 
Amersham (31). After cloning the 2958 bp Pst I!Sal I fragment from pBR322 into RF 
M 13 mp 18 using standard procedures (29), single stranded phage was isolated and 
annealed to the oligonucleotides coding for creation of silent mutations creating Sac I and 
Ksp I restriction sites by heating to 95°C and slowly cooling to room temperature. 
Mutagenesis was then done using the Eckstein protocol (28). Twenty plaques were tested 
and sequenced using the Sanger dideoxy method (32). DNA having the desired mutations 
were subcloned back into pBR322 to produce pJN-Sax (Figure 7). The presence on the 
Sac I and Ksp I sites were then confirmed by restriction mapping. 
DNA Sequencing. Plasmid DNA was sequenced using a modification of the 
Sanger dideoxy method for denatured, double-stranded DNA (32). Plasmid DNA 
together with sequencing primer was boiled for 5 min., then snap frozen in dry 
ice/ethanol. Chain extension reactions were performed with a SEQUEN ASE™ kit from 
United States Biochemical (33). Radioactive labeling was accomplished with a-35S-
dA TP. Labeled DNA was separated on 8% polyacrylamide sequencing gels, and resulting 
gels were dried in vacuo. Kodak AR x-ray film was then exposed in the presence of the 
sequencing gel for 12 hours. 
Cassette Mutagenesis. Cassette mutagenesis is a technique wherein mutations can 
be introduced into a gene of interest using complementary synthetic oligonucleotides in 
conjunction with restriction endonucleases, followed by ligation (Figure 8). Provided that 
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Figure 8. A schematic overview of cassette mutagenesis. 
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can be accomplished with out the use of a single stranded vector or subcloning routines. 
The complementary synthetic oligonucleotides containing a degenerate codon at residue 
132 and overhangs corresponding to Sac I and Pvu I restriction endonuclease sites 
(Figure 10) were kinased by standard procedures (29) and annealed by heating to 95°C in 
10 mM Tris-HCl, pH 7 .5, 10 mM MgCl2, 50 mM NaCl, and then slowly cooled to room 
temperature. A three fragment ligation was then carried out as follows: pJN-Sax was 
linearized with BamH I and isolated from a low melting agarose gel (29). The linear DNA 
was then digested with Pvu I (tube 1) and Sac I (tube 2). The 3313 bp piece from the Pvu 
I digest and the 2029 bp fragment from the Sac I digest were isolated from a low melt 
agarose gel. These two fragments were mixed with equimolar concentrations of the 
synthetic cassette insert, and ligated in a mixture of 10 mM Tris-HCl, pH 8.0, 5 mM 
MgCl2, 5 mM DTT, 1 mM ATP, and 1 unit T4 DNA ligase for 2 hours at room 
temperature. 10 ~1 of this ligation mixture were transformed directly into competent E 
coli. strain D1210 and cells were spread onto L plates containing 50 ~g/ml kanamycin. 
The plasmid DNA was isolated by alkaline lysis, and subjected to restriction analysis and 
sequencing. Successful insertion of the cassette results in the removal of the Ksp I site, 
therefore allowing a quick screen for positive mutants. 
Phenotypic Screening. Following identification of all 19 mutants, each was 
grown to late log phase in LB/kan. 10 J,Ll of cells were diluted 105 and plated onto L plates 
with varying concentrations of ampicillin, benzyl penicillin, and cephalothin (25, 50, 75, 
100, 200, 400, 800, 1200, 1600, 2000 ~g/ml). These plates were incubated at 37°C for 12 
hours, and presence or absence of colony growth for each mutant noted. 
Western Blots. The levels of mutant J3-lactamase present in the cells were assayed 
by Western blot analysis of whole-celllysates prepared in the following manner: E. coli 
were grown in LB containing kanamycin (50 ~g/ml) to late log phase (ODu = 1) at 37°C. 
1.5 ml of each culture was centrifuged to pellet the cells, which were then resuspended in 








Figure 9. Syntheitic oligonucleotide "cassette" coding for all 
20 amino acids at position 132 for pJN -Sax vector 
Pvu I 
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100 J •.tl of protein loading buffer and heated to 95°C for 10 minutes to lyse the cells. 
Aliquots of 20 J,Ll each were loaded onto a 15 em 15% polyacrylamide gel ( 4% stack) and 
electrophoresed at 5 rnA for 12-16 hours. Protein was then transferred from the gel onto 
DEAE nitrocellulose using a Bio-Rad Transblot cell (120 V for 6 hours). f3-lactamase was 
visualized following binding of rabbit anti-f3-lactamase (34) using the highly sensitive 
Vectastain ABC immunoperoxidase system (35). 
Protein Expression and Purification. To facilitate expression, the mutant f3 -
lactamases were subcloned into pJN, and expression vector which was developed in this 
lab (36). It contains the f3-lactamase gene under control of the tac promoter (37), and well 
as a kanamycin gene for a selection marker. Synthesis of f3-lactamase is induced by the 
addition of IPTG. 
One liter cultures of E.coli D1210 containing mutant plasmid were grown in X 
broth (25 g Tryptone, 7.5 g yeast extract, 20 ml 1M MgS04, 50 ml 1 M Tris-HCl pH 7.5 
per liter) containing 50 J.Lg/ml kanamycin for 12-14 hours at 37°C. IPTG was added to a 
final concentration of 0.1 mM and growth continued for 1 hour at 37°C. Cells were 
centrifuged in 250 ml bottles in a GSA rotor for 10 minutes at 10,000 rpm. f3-lactamase, 
which is located in the periplasm, was released by osmotic extrusion (38). Briefly, 
pelleted cells were resuspended in 1/10 of the culture volume in a sucrose solution (450 
g. sucrose, 0.5 g. EDTA, 25 mM Tris pH 8.0, per liter). This was shaken for 30 minutes, 
followed by centrifugation at 7000 rpm for 30 minutes. The cells were then resuspended 
in cold water (equal volume to sucrose solution) and shaken at 4°C for thirty minutes. 
Centrifugation at 12000 rpm for 45 minutes afforded relatively cell free perplasmic 
lysate. The sample containing the perplasmic proteins was reduced to -1 ml using a 
Diaflow cell (Amicon) under nitrogen. The resulting solution was then filtered through a 
Schleicher and Schuell 0.22 mm Uniflow filter to remove any cellular debris. 
Further purification was carried out using FPLC (fast protein liquid 
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chromatography) first with a HR16/10 Fast Flow MonoQ™ column, followed by a 
HRl0/10 MonoQ™, both by Pharmacia. Crude protein was loaded onto the fast flow 
column, and the column was washed in 100% A (25 mM triethanolamine (TEA), pH 
7.65). Then crude ~-lactamase was eluted with 20%B (25 mM TEA, 1M NaCI). This 
protein was loaded onto the HR 10/10 column in 25 mM TEA and eluted with a salt 
gradient. The gradient used was: t=O, 100% A, t=5, 100% A, t=35, 80%A, 20%B, t=45, 
100% B. The flow rate was 1.0 ml/minutes. Elution was monitored by A280· Peak 
fractions were pooled and dialyzed versus 50 mM potassium phosphate, pH 7.0. Protein 
concentrations were estimated from OD280 using an extinction coefficient of 29,400 M-
lcm-1(2). Samples were run on 15% polyacrylamide gels (as in western blot) and stained 
with Coomasie blue to gauge purity. 
Kinetics. Michaelis-Menten kinetic parameters (kcat• KM, and kcatfKM) for mutant 
~-lactamases were determined by Hanes plots using initial rates (39). Reactions were 
carried out at 30°C in 50 mM potassium phosphate pH 7.0. All reagent were maintained 
at 30°C prior to beginning the assay to avoid error from temperature flux. An HP 8420 
spectrophotometer was used for the assays, with quartz cells of pathlength 1 em at 
wavelength 232 nm. 
Identification of Acyl-enzyme Intermediate. If the deacylation step is primarily 
affected by the mutation at 132, acyl-enzyme would build up. Previous studies on residue 
166 in RTEM-1 j3-lactamase have shown that this acyl-enzyme can be detected using 
14C-benzyl penicillin (22). 14C-benzyl penicillin (Amersham) was reacted with 
concentrated osmotic extrusion from 10 mls of saturated cells according to published 
procedures (22). The mutant E166V was run as a positive control, as it has been shown 
that this mutation causes acyl-enzyme to build up (40). Reactions were loaded onto 15% 
polyacrylamide gels and electrophoresed as in western blot. The gels were fixed (40% 
MeOH:10%HOAc:50%H20), followed by treatment with Amplify™ (Amersham) 
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according to manufacturers directions. The gel was dried in vacuo, and Kodak AR film 
was exposed in the presence of the gel. 
RESULTS 
Mutagenesis. Oligonucleotide-directed mutagenesis was used to create unique Sac 
I and Ksp I sites within the existing f3-lactamase gene (from pBR322) in Ml3. Restriction 
endonuclease (Figure 11) and sequencing analysis (Figure 12) confirmed the presence of 
these sites. Site-saturation of residue 132 was accomplished using cassette mutagenesis 
with oligonucleotides degenerate at codon 132. The cassette DNA contained sticky ends 
complimentary to Pvu I and Sac I sites. A three fragment ligation with these two enzymes 
along with BamH I was used to insert the cassette into the f3-lactamase gene (Figure 13). 
Following ligation and transformation, colonies were picked, their plasmid DNA isolated, 
screened by restriction digest with Ksp I, and positive colonies sequenced. 60 colonies 
were sequenced, with 17 mutants found (Figure 14). The mutations N132I, N132Q, 
N132V were not found. Oligonucleotide cassettes were then synthesized coding 
specifically for each of these mutants (N132I-ATC, N132Q-CAG, Nl32V-GTG), and a 
similar three piece ligation was performed. Colonies were isolated, plasmid DNA 
sequenced, and identity of the mutants confirmed. 
Phenotypic Screening. Each of the mutants were grown to late log phase and 
plated on varying concentrations of antibiotic following dilution. The results of these 
experiments are shown in Figure 15. Only four mutants, N132C, N132D, Nl32E, N132Q 
showed any appreciable activity. Most of these would be considered conservative 
changes, with the exception of N 132C. These experiments were repeated under a number 
of dilution conditions to insure repeatable results. 
Stability of Mutant Enzymes. The stability of mutant enzymes produced were 
assayed by Western blot analysis. All mutants exhibited expression and stability's 
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- 5402 bp 
-uncut 
Figure 10. Agarose gel showing the presence of Sac I and Sac II restriction sites in piN-
Sax. Lane 1, pJN-N132C cut with Sac I. Lane 2, pJN-N132C cut with Sac II. Lane 3, 
uncut pJN-N132C. Lane 4, molecular weight marker. Lane 5, pJN-Sax cut with Sac I. 
Lane 6, pJN-Sax cut with Sac II. Lane 7, uncut pJN-Sax. Successful ligation of N132X 
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Figure 12. Sequencing gel showing the presence of Sac II site (CCGCGG) in pJN-Sax. 
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1 2 3 
- 3313 bp 
- 2087bp 
Figure 13. Agarose gel showing fragments used in cassette mutagenesis of residue 132. 
Lane 1, molecular weight marker. Lane 2, pJN-Sax cut with BamH I and Pvu I. Lane 3, 
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Figure 14. Sequencing gel of four N132X colonies; TCC (Ser), TCC (Phe), ACC (Thr), 
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Figure 15. Plot of phenotypic resistance for N 132X mutants. 
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comparable to wild-type (data not shown). This indicates that the lack of activity of the 
mutants is due to structural changes in the protein rather than instability, incorrect 
folding, or lack of protein expression. 
Isolation of Mutant Enzymes. Three mutants (N132C, N132D, Nl32Q) were 
chosen for kinetic analysis, as these appeared to possess significant enough activity to 
assay by spectrophotometric means. Two liters of media with proper antibiotic were 
grown to saturation at 37°C. IPTG was added (24 mg/1) and incubation continued for 1 
hour. Following osmotic extrusion, concentration in an Amicon unit afforded -lOml of 
crude protein. This was chromatographed first by FPLC on a HR16/10 Fast Flow column 
with the 20%B cut retained. After dialysis into Buffer A and concentration by Amicon, 13-
lactamase was purified on a Mono Q™ column by FPLC (Figure 16). Fractions 
containing 13-lactamase and purity were identified by PAGE (Figure 17). 
Kinetics. Steady-state kinetic analysis of three mutants (N132C, Nl32D, N132Q) 
was undertaken, with the kinetic scheme shown in Figure 18. The hydrolysis reaction is 
followed by decrease in absorbance at 232 nm, which indicates the opening of the 13-
lactam ring (Figure 19). The results are shown in Table 1. Increases in KM for the three 
mutants indicate that residue 132 is important in binding substrate. The dramatic decrease 
in kcat ( -1 o-4) indicates that 132 is significantly involved in catalysis, most probably 
acylation. 
Presence of Acyl-Enzyme Intermediate. Previous experiments in our lab and 
elsewhere have indicated that residue 166 is involved in deacylation, functioning as a 
general base (22, 41) . Mutations at residue 166 give rise to a stable acyl-enzyme 
intermediate which can be trapped. Reaction of 166 mutants with 14C-benzyl penicillin 
lead to accumulation of radio-labeled 13-lactamase, which can be identified by PAGE and 
autoradiography. This assay was used to probe for stable acyl-enzyme intermediates with 




Figure 16. FPLC trace for purification of N 132C mutant. 13-lactamase is peak @ 15% B 
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Figure 17. PAGE analysis of FPLC fractions for purification of N 132C mutant. Fractions 
5 and 6 contain ~-lactamase. 
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Figure 19. Plot of absorbance vs. time for the hydrolysis of benzyl penicillin catalyzed by 






~} KM-WMl ~M:.l} relative rate 
980 42 2.5 X 107 1 
2.0 400 5.0 X 103 2.2 X 10-4 
0.43 130 3.3 X 103 1.4 X 10-4 
0.11 120 9.2 X 1()2 4.0 X 10-5 
Table 1. Kinetic parameters for hydrolysis of benzylpenicillin catalyzed by 
R TEM -1 13-lactarnase 
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number of 132 mutants (A, C, D, F, G, M, Q, S) were assayed along with E166V as a 
positive control. Repeated attempts to see stable intermediates with 132 mutants were 
unsuccessful (Figure 20). This negative result indicates that mutations at position 132 
either affect acylation only, or acylation and deacylation equally. 
DISCUSSION 
The level of understanding of enzymatic mechanisms has increased greatly over the 
past 15 years, largely due to crystallographic and mutagenesis studies. However, the 
subtleties of catalysis remain elusive. In the past our lab has investigated many of the 
catalytically important residues by site-saturation mutagenesis. We have utilized site-
saturation for a number of reasons including ease of mutation, cloning efficiencies and 
screening. But primarily, generation of all 20 amino acids at a specific residue has lead to 
results not anticipated a priori. For example, site-saturation of glutamate 166, the residue 
believed to be responsible for deacylation of the acyl-enzyme intermediate, gave three 
mutants with activity; aspartate, histidine and tyrosine (42). Previous reports of 
mutagenesis at residue 166 did not include the E166H and E166Y mutations (22). The 
activity of these unexpected functional mutations leads to a greater understanding of the 
structural requirements of catalysis. Thus, site-saturation mutagenesis has assumed an 
important role in our lab's investigations of ~-lactamase activity. 
Asn 132 was originally chosen as a target following analysis of the B. licheniformis 
structure by Moews et al. (43). The asparagine side chain amide appeared to be 
strategically positioned to function as a hydrogen bond donor and/or acceptor for 
substrate binding and/or catalysis. Site-saturation of residue 132 shows that only four 
amino acid substitutions give appreciable activity. 
Phenotypic screening is the initial test for mutants generated. Resistance to antibiotics 
indicates activity of the mutant ~-lactamase enzyme. Again site-saturation yielded some 
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Figure 20. Autoradiograph of PAGE using N132X mutants and 14C-benzyl penicillin. 
Lane 1, E166V positive control. Lane 2, N132A. Lane 3, N132C. Lane 4, N132D. Lane 
5, N132N (negative control). Lane 6, N132S. Lane 7, moleculare weight marker. 
64 
surprise. the N132Q mutant showed activity; this is not surprising as this is a conservative 
change, only increasing the side-chain length by one CH2 unit. Similarly, the activity of 
Nl32D and Nl32E were not unexpected. This result does indicate that the side chain 
group is probably functioning as a hydrogen bond acceptor. If it were a donor, the 
carboxylate side chains, which should be deprotonated at pH 7 (pKa -4), would not 
possess a hydrogen atom to donate. The activity of Nl32C is at first surprising, especially 
considering the inactivity of N 132S. However this result can be rationalized, again if 
residue 132 is considered to be a hydrogen bond acceptor. Two factors could be 
influencing the difference in activities of Nl32C and Nl32S. A steric argument could be 
put forth, as the sulfur of cysteine is larger than the oxygen of serine. Thus the cysteine 
side chain would extend slightly further into the active site than serine. Secondly, and 
possibly more importantly, the pKa of the thiol is significantly lower than the serine 
hydroxyl (pKa -8 vs. pKa -12). Thus the cysteine thiol could be largely deprotonated at 
pH 7, serving as a much better hydrogen bond acceptor. 
Further study on the active mutants involved steady-state kinetic analysis. To a gross 
approximation, increases in K M would indicate a decrease in binding efficiency, 
indicating disruption of enzyme-substrate interactions. The three mutants investigated, 
N132C, N132D, N132Q all show increased KM's, although none by more than an order of 
magnitude. This suggests that residue 132 does influence substrate binding, but not to a 
large degree. 
Mutations at 132 do have a large influence on the pseudo first-order rate constant, 
kcat· All three mutants show kcat down by at least 1Q3. Therefore it appears that the side-
chain of residue 132 does influence catalysis. Due to the nature of the mechanism of~­
lactamase, there are two catalytic steps that could be involved: acylation and deacylation. 
It has been shown that residue 166 is involved in deacylation, as illustrated by the buildup 
of acyl-enzyme intermediate in glutamate 166 mutants. If residue 132 is involved in 
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deacylation as well, a similar phenomenon would be expected. However repeated 
attempts to trap acyl-enzyme intermediate with 132 mutants were unsuccessful. This 
suggests two possibilities: either both steps are equally affected or acylation only is 
affected. The later explanation is more attractive, due to a number of reasons. First, the 
active site is separated by the substrate into two halves, with acylation taking place on 
one face of the substrate, and deacylation taking place on the ot~er. Thus one would 
assume that a mutation would affect either one step or the other. Secondly, the recent 
crystal structure of the acyl-enzyme intermediate suggests that 132 is interacting with Lys 
73, a residue which is thought to be directly responsible for acylation. 
The publication of the acyl-enzyme structure shed light onto the intricacies of the 
active site, and suggested roles for many of the residues surrounding the substrate. The 
main feature of the mechanism put forth by Strynadka et al not suggested by other groups 
is the involvement of the amine side chain of Lys 73 in acylation; specifically that it 
functions as a general base, extracting a proton from the active site nucleophile Ser 70 
(Figure 5). The structure also showed Asn 132 to interact with Lys 73, either serving to 
orient the amine base, or perhaps to help lower the pKa of Lys 73, a necessity for it to 
function as a general base. Thus the mechanism suggests a catalytic importance for 
residue 132 specific for the acylation reaction, and our results are in line with this 
hypothesis (Figure 21). 
It is obvious from these results that the interactions in the active site of an enzyme are 
many and often subtle. Identification of the main players in catalysis are often easy to 
identify, particularly with good crystal structures available. But the intricacies are often 
more elusive, as illustrated by the function of residue 132. Site-saturation shows that 
acceptable interactions of amino acids are difficult to predict. 
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Figure 21. Detailed mechanism suggested by Strynadka et al. for 13-lactamase catalyzed 
hydrolysis of 13-lactam antibiotics. 
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Chapter 3 
Combinatorial Mutagenesis of Residues 73 and 166 in RTEM-1 ~-lactamase 
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INTRODUCTION 
The ~-lactamases are a group of related enzymes characterized by their ability to 
confer resistance to penam and cephem antibiotics such as penicillin and cephalothin 
(1)(Figure 1). The antibiotic is rendered inactive by enzyme catalyzed hydrolysis of the~­
lactam (2). The mechanism is proposed to involve an active site serine responsible for 
nucleophilic attack on the ~-lactam ring, leading to an acyl-enzyme intermediate which is 
subsequently hydrolyzed by a bound water molecule (Figure 2). 
Over 80 ~-lactmases have been identified, and divided into three categories based 
on sequence homology, size, and activity (3). The class A ~-lactamases include the 
RTEM ~-lactamases (RTEM-1, 2 and 3) of Escherichia coli (4), Staphylococcus aureus 
PCl (5), Bacillus licheniformis 749/C (6), and Bacillus cereus 569/HI (7). All of these 
enzymes exhibit considerable sequence homology (-30%) and have a molecular weight 
of around 30 kD. There are only two class B ~-lactamases, those of B. cereus and Proteus 
maltophilia (8). The class B ~-lactamases differ from the class A ~-lactamases in that they 
have molecular weights of approximately 23 kD and form a metalloenzyme complex with 
zinc. The class C ~-lactamases are the structurally largest at 40 kD and include 
Enterbacterium cloacae P99 and Escherichia coli K12 (9). In addition to size, the three 
classes also differ in substrate specificity. The class A ~-lactamases preferentially 
hydrolyze penams, while the other two classes target the cephem antibiotics. Sequence 
alignments of the class A ~-lactamases have indicated a number of strictly conserved 
residues, including Lys 73 and Glu 166 (Figure 3)(1). 
RTEM-1 ~-lactamase is a 28.5 kD soluble protein isolated from E. coli. Like the 
other class A ~-lactamases, RTEM preferentially hydrolyzes penam antibiotics over 
cephems. The rate of penam hydrolysis approaches diffusion control limits, with a 
second-order rate constant on the order of 108 (10). The ~-lactam substrate is subjected to 
nucleophilic attack on the lactam carbonyl group by an active site serine (Ser 70 in 
72 
~NH S ~NH S u ~ . OJ[f--(< HO NH, 0 O)f~oy 
COOH COOH 0 
ampicillin cephalosporin c 
Figure 1. Representative 13-lactam antibiotics. Ampicillin is a member of the 
penam family, cephalosporin c is a cephem. Arrow points to bond 















Figure 2. Overall reaction catalyzed by f3-lactamase. 
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(a ) 63-e R F p m m ~ T f K v 1 1 c g a v L s- 8 3 
(b) 63-k R F a y a ~ T s K a ~ n s a ~ 1 L e - 83 
(c) 63-e R F a f a ~ T ~ K a 1 t v g v 1 L q-83 
(d ) 63-q R F a f a ~ T y K a 1 a a g v 1 L q-83 
(a) 156-D h v T r 1 d R wE pEL N e a ~ P n-176 
(b ) 156-D k v T n p v RyE ~ E L N y y s P k-176 
(c ) 156-D e v T n p e R f E p E L N e v n P g-17 6 
(d) 156-D r i T m s n R f E t E L N e a ~ P g-176 
Figure 3. Amino acid sequence alingment of four class A 13-lactamases in the regions of 
Lys 73 and Glu 166 (in bold). The sequences are: (a) Escherichia coli pBR322 RTEM-1; 
(b) Staphylococcus aureus PCI; (c) Bacillus licheniformis 749/C; (d) Bacillus cereus 
569/H. The numbering starts from then-terminus of the longest form of the B. 
licheniformis enzyme that has been isolated, and takes account of the gaps postulated in 
the currently known sequences to obtain optimal matching. 
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RTEM). Nucleophilic attack proceeds through a tetrahedral intermediate which is 
proposed to be stabilized by an oxyanion hole (11), similar to that observed in the serine 
proteases (12). The resulting acyl-enzyme intermediate is rapidly hydrolyzed, leading to 
an inactive antibiotic (13). 
A considerable amount of research has been performed in our laboratory to 
investigate the roles of several important residues in RTEM-1 ~-lactamase including Thr 
71(14), Lys 73 (15), Glu 166 (16), Lys 234 (17), Ala 237 (18), Ser 130 (19), and residues 
237-240 (20). Other research has been directed towards the generation of mutants at Ser 
70 (21, 22). In spite of the wealth of information concerning catalysis in RTEM-1 ~­
lactamase, questions still persist. 
Initial crystallographic studies indicated that two conserved active site residues, 
Lys 73 and Glu 166, could interact in a salt bridge or hydrogen bonding scheme, and 
were important for catalysis (Figure 4)(11). Previous studies in our labs analyzed these 
sites singly by site saturation techniques (15, 16). Any changes at residue 73 resulted in 
serious reductions in catalysis. Site 166 however showed that some alterations were 
tolerated, with mutations to Asp, His and Tyr giving phenotypic resistance. 
An attempt to change the polarity of this putative salt bridge was made by the 
generation of the double mutant K73E/E166K. This mutant showed no phenotypic 
activity. It was thought that perhaps some other combination of mutations at sites 73 and 
166 could give competent enzyme. The technique of combinatorial mutagenesis can be 
used to generate large numbers of combinatorial mutants providing proper restriction 
sites exist in the gene of interest (Figure 5). Since site saturations at residues 73 and 166 
had been previously accomplished, the 400 possible combinations could be attained using 
a convenient Pvu I site. Screening for low levels of ampicillin resistance allows rapid 
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Phenotypic resistance for K73X mutants 
F G H 
[J ampicillin 
K L M N P Q R S T V W Y 
amino acid 
Phenotypic resistance ofE166X mutants 
F G H 
IZI ampicillin 
D cephalothin 
K L M N P Q R S T V W Y 
amino acid 
Figure 5. Plots of phenotypic resistance for K73X and E166X mutants. 
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(3737 bp fragment} 
- Transform into D1210 and screen for activity 
Figure 6. Combinatorial mutagenesis scheme 
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MATERIALS AND METHODS 
Enzymes and Chemicals. Enzymes were purchased from Boehringer Mannheim 
Biochemicals, New England Biolabs, and Promega. Antibiotics were from Sigma. 
Radioactive compounds were supplied by Amersham. Isopropyl-~-thiogalactoside (IPTG) 
was from International Biotechnologies Inc. (IBI). Molecular biology grade reagents 
agarose, acrylamide, phenol, chloroform, ammonium persulfate were from Bio Rad. 
Bacterial Strains. Escherichia coli were used in all experiments. Plasmid DNA 
was grown in strain HBIOl (23); the pJN expression vector was grown in strain D1210, 
which is lac iQ. Culture media was L broth unless otherwise indicated. Cells were made 
competent for transformation of plasmid DNA using a process adapted from Hanahan 
(24). 
DNA. Oligonucleotides were synthesized by the Caltech Microchemical Facility 
using phosphoramidite chemistry (25) on an Applied Biosystems automated DNA 
synthesizer 380A. Degenerate oligonucleotides were made equimolar in A, C, G, and T at 
positions 1 and 2 of the codon, and inC and Gat position 3. These oligonucleotides were 
purified by preparative polyacrylamide gel electrophoresis. 
Wild-type plasmid pBR322 and bacteriophage M13 mp18 replicative form (RF) 
DNA were purchased from Bethesda Research Laboratories. Mutant plasmids and RF 
phage were purified from E. coli by alkaline lysis method (26, 27). Single-stranded phage 
DNA was prepared from phage supernatant by precipitation with 20% polyethylene 
glycol-6000/2.5 M NaCI (28) followed by phenol/chloroform extraction and ethanol 
precipitation. 
Restriction digest typically used 10-20 J.l.g plasmid DNA, 2-5 units of restriction 
enzyme, and 2 Ill lOX digest buffer in 20 Ill at 37°C for 1-2 hours. DNA restriction 
fragments were run in 1.2% low melt agarose gels, visualized with ethidium bromide, and 
isolated by established procedures (27). 
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Oligonucleotide-directed Mutagenesis. Two new restriction endonuclease sites 
were added previously to facilitate cassette mutagenesis and screening (26) . 
Oligonucleotide-directed mutagenesis of the existing ~-lactamase gene in a modified 
pBR322 plasmid (29) was used to create a Sea I site, and an Ava I site for cassette 
mutagenesis of position 73. Cassette mutagenesis of position 166 was made possible by 
the creation of unique Mlu I, Sba I, and Sac I sites (16). This was accomplished using the 
in vitro mutagenesis system ™ by Amersham (30). 
DNA Sequencing. Plasmid DNA was sequenced using a modification of the 
Sanger dideoxy method for denatured, double-stranded DNA (31 ). Plasmid DNA 
together with sequencing primer was boiled for 5 minutes, then snap frozen in dry 
ice/ethanol. Chain extension reactions were performed with a SEQUENASETM kit from 
United States Biochemical (32). Radioactive labeling was accomplished with a-35s-
dA TP. Labeled DNA was separated on 8% polyacrylamide sequencing gels, and resulting 
gels were dried in vacuo. Kodak AR x-ray film was then exposed in the presence of the 
sequencing gel for 12 hours. 
Cassette Mutagenesis of Position 73 Site saturation of residue 73 was 
accomplished by SteveS. Carroll in our laboratories previously (Figure 7)(15). Briefly, 
complementary synthetic oligonucleotides containing a degenerate codon at residue 73 
and overhangs corresponding to Ava I and Sea I sites were kinased and annealed by 
standard procedures (27). Plasmid pBR-CR7 (15) was digested with Sea I and Sal I, and 
the 3286 bp fragment was isolated from a low melt agarose gel (27). Plasmid pBR322-
XN1 (15) was digested with Ava I and Sal I, and the 1042 bp fragment isolated from a 
low melt agarose gel. These two fragments were mixed in equimolar concentrations with 
a five-fold excess of the synthetic cassette insert, and ligated and transformed directly 
into competent E coli. strain HB 101 and cells were spread onto L plates containing 15 
11g/ml tetracycline. The plasmid DNA was isolated by alkaline lysis, and subjected to 
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restriction analysis and sequencing. 
Cassette Mutagenesis of Position 166. Site saturation of residue 166 was 
accomplished previously by William J. Healy in our labs (16). Briefly, complementary 
synthetic oligonucleotides degenerate at position 166 with overhangs corresponding to 
Mlu I and Sac I sites were kinased and annealed as above. Plasmid pBR322-Mlu (16) was 
digested with Mlu I and Sal I, with the 1335 bp fragment isolated. Plasmid pBR322-Sac 
(16) was digested with Sac I and Sal I, with the 3000 bp fragment isolated. These 
fragments were ligated with synthetic cassette as above and transformed into HB 101 E. 
coli and plated on L plates containing 15 Jlg/ml tetracycline. 
Combinatorial Mutagenesis. Combinatorial mutagenesis is a technique that uses 
existing site saturation mutations to generate combinations of mutations at multiple sites 
(Figure 6). Equimolar mixtures of pBR322 plasmids containing the site-saturation's from 
73 and 166 were made. These mixtures were digested with EcoR I and Pvu I according to 
standard procedures (27), and the resulting fragments isolated from a low melting agarose 
gel. The 626 bp piece from the K73X mixture was ligated with the 3737 bp piece form 
the E166X mixture. The ligation mixture was then transformed directly into competent 
E. coli strain 01210, with the cells plated out on low (10-25 Jlg/ml) concentration 
ampicillin plates also containing tetracycline. Colonies that grew were sequenced by 
dideoxy methods. 
Phenotypic Screening. Following identification of all 19 mutants, each was 
grown to late log phase in LB/kan. 10 J.Ll of cells were diluted 105 and plated onto L plates 
with varying concentrations of ampicillin, benzyl penicillin, and cephalothin (25, 50, 75, 
100, 200, 400, 800, 1200, 1600, 2000 Jlg/ml). These plates were incubated at 37°C for 12 
hours, and presence or absence of colony growth for each mutant noted. 
pJN Subcloning. To facilitate expression, the mutant 13-lactamases were 
subcloned into pJN, an expression vector which was developed in this lab (Figure 7) (33). 
(Plasmid DNA J 
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Figure 8. pJN expression vector. 
BstB I( t2S'1) 
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It contains the ~-lactamase gene under control of the tac promoter (34), and well as a 
kanamycin gene for a selection marker. Synthesis of ~-lactamase is induced by the 
addition of IPTG. The subcloning scheme is shown in Figure 8. Plasmid DNA from 
active combinatorial mutants was isolated as described above, and digested with EcoR I 
and Bam HI, with the resulting 3986 bp fragment isolated from a low melt agarose gel. 
The pJN expression vector plasmid DNA was similarly digested with EcoR I and BamH 
I, with the resulting 1416 bp fragment isolated. These two fragments were mixed in 
equimolar amounts with T4 DNA ligase and proper buffer at room temperature for 2 
hours, followed by transformation and plating onto L plates with 50 JJ.g/ml kanamycin as 
described above. 
Protein Expression and Purification. One liter cultures of E.coli 01210 
containing mutant plasmid were grown in X broth containing 50 JJ.g/ml kanamycin for 12-
14 hours at 37°C. IPTG was added to a final concentration of 0.1 mM and growth 
continued for 1 hour at 37°C. Cells were centrifuged in 250 ml bottles in a GSA rotor for 
10 minutes at 10,000 rpm. ~-lactamase, which is located in the periplasm, was released by 
osmotic extrusion (10). The sample containing the perplasmic proteins was reduced to -1 
ml using a Diaflow cell (Amicon) under nitrogen. The resulting solution was then filtered 
through a Schleicher and Schuell 0.22 m Uniflow filter to remove any cellular debris. 
Further purification was carried out using FPLC (fast protein liquid 
chromatography) first with a HR16/10 Fast Flow MonoQ™ column, followed by a 
HRI0/10 MonoQ™, both by Pharmacia. Crude protein was loaded onto the fast flow 
column, and the column was washed in 100% A (25 mM triethanolamine (TEA), pH 
7.65). Then crude ~-lactamase was eluted with 20%B (25 mM TEA, 1M NaCl). This 
protein was loaded onto the HR 10/10 column in 25 mM TEA and eluted with a salt 
gradient. The gradient used was: t=O, 100% A, t=5, 100% A, t=35, 80%A, 20%B, t=45, 
100% B. The flow rate was 1.0 ml/min. Elution was monitored by A280· Peak fractions 
pBR322 K73X/E166 
4363 bp 
1. Digest with EcoR I and BamH I 
2. Isolate 3986 bp fragment 
2-fragment ligation 
with T4 DNA ligase 
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(pJN K73X/E166X) 
BamH I( 1414) 
1. Digest with EcoR I and BamH I 
. Isolate 1416 bp fragment 
BamH I( 1414) 
Figure 9. Scheme for subcloning mutants into pJN expression vector. 
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were pooled and dialyzed versus 100 mM potassium phosphate, pH 7.0. Protein 
concentrations were estimated from 00280 using an extinction coefficient of 29,400 M-
1cm-1(2). Samples were run on 15% polyacrylamide gels (as in western blot) and stained 
with Coomasie blue to gauge purity. 
Kinetics. Michaelis-Menten kinetic parameters (kcat• KM, and kcatiKM) for mutant 
~-lactamases were determined by Hanes plots (35) using initial rates. Reactions were 
carried out at 30°C in 100 mM potassium phosphate pH 7.0. All reagent were maintained 
at 30°C prior to beginning the assay to avoid error from temperature flux. An HP 8420 
spectrophotometer was used for the assays, with quartz cells of pathlength 1 em at 
wavelength 232 nm. 
RESULTS 
Mutagenesis. Oligonucleotide-directed mutagenesis was used by SteveS. Carroll 
in our group to create unique Ava I and Sea I sites within the existing ~-lactamase gene 
(from pBR322) in M13 (15). Sequencing and restriction endonuclease analysis confirmed 
the presence of these sites. Site-saturation of residue 73 was accomplished using cassette 
mutagenesis with oligonucleotides degenerate at codon 73 (15). Oligonucleotide-directed 
mutagenesis was used by William J. Healy in our group to create unique Mlu I, Sba I, and 
Sac I sites within the existing 13-lactamase gene (from pBR322) in M13 (16). Sequencing 
and restriction endonuclease analysis confirmed the presence of these sites. Site-
saturation of residue 166 was accomplished using cassette mutagenesis with 
oligonucleotides degenerate at codon 166 (16). 
Combinatorial mutagenesis used the previously created site saturation's to 
generate 400 possible combinations of amino acids at two conserved residues in the 
RTEM-1 13-lactamase gene. Equimolar amounts of plasmid DNA coding for all 20 amino 
acids at sites 73 and 166 was digested with EcoR I and Pvu I, followed by isolation from 
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low melt agarose gel (Figure 9). Ligation reactions with equimolar amounts of digested 
plasmid DNA were repeatedly transformed into competent D1210 E. coli, and plated on 
L plates with 50 J..Lg/ml kanamycin and 10 to 25 J..Lg/ml ampicillin to screen for active 
mutants. A total of 23 colonies were isolated and their plasmid DNA sequenced (Figure 
10). Only three mutants were found (along with wild-type)-K73K/E166D, K73K/E166H, 
K73K/E166Y (data not shown). 
Phenotypic Screening. Each of the site saturation mutants were grown to late log 
phase and plated on varying concentrations of antibiotic following dilution in previous 
experiments (15, 16). The results of these experiments are shown in Figure 11. For 
residue 73, none of the mutants showed any appreciable activity (<0.5% that of wild-
type) towards usual substrates. A few mutants at position 166 showed activity, 
specifically E166D, E166H, and E166Y. 
Stability of Mutant Enzymes. The stability of mutant enzymes produced were 
previously assayed by Western blot analysis. All K73X mutants exhibited expression and 
stability's comparable to wild-type (data not shown)(15). This indicates that the lack of 
activity of the mutants is due to structural changes in the protein rather than instability, 
incorrect folding, or lack of protein expression. All E 166X mutants, with the exception of 
E166R and E166K, exhibited stability comparable to wild-type (data not shown)(16). 
Isolation of Mutant Enzymes. The active combinatorial mutants (K73K/E166D 
and K73K/E166H) were chosen for kinetic analysis, as these appeared to possess 
significant enough activity to assay by spectrophotometric means. Two liters of media 
with proper antibiotic were grown to saturation at 37°C. IPTG was added (24 mg/ml) and 
incubation continued for 1 hour. Following osmotic extrusion, concentration in an 
Amicon unit afforded -10 ml of crude protein. This was chromatographed first by FPLC 
on a HR16/10 Fast Flow column with the 20%B cut retained. After dialysis into Buffer A 





Figure 10. Agarose gel showing restriction digests and fragments used in combinatorial 
mutagenesis. Lane 1, pBR322-K73X cut with EcoR I and Pvu I. Lane 2, pBR322-E166X 
cut with EcoR I and Pvu I. Lane 3, Molecular weight marker. 
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(Figure 11). Fractions containing 13-lactamase and purity were identified by PAGE. 
Kinetics. Steady-state kinetic analysis of three mutants (E166D, E166H, E166Y) 
was undertaken, with the kinetic scheme shown in Figure 12. The hydrolysis reaction is 
followed by decrease in absorbance at 232 nm, which indicates the opening of the 13-
lactam ring. The results are shown in Table 1. Decreases in kcat for the mutants indicate 
that residue 166 is important in catalysis, while KM values near that of wild-type show 
that residue 166 has little effect on substrate binding. The pH profiles for the two mutants 
are nearly identical to those for wild-type (Figure 13). 
DISCUSSION 
In the past our lab has investigated many of the catalytically important residues by 
site-saturation mutagenesis. We have utilized site-saturation's for a number of reasons 
including ease of mutation, cloning efficiencies and screening. But primarily, generation 
of all 20 amino acids at a specific residue leads to results not anticipated a priori. For 
example, site-saturation of Glu 166, the residue believed to be responsible for deacylation 
of the acyl-enzyme intermediate, gave three mutants with activity; aspartate, histidine and 
tyrosine (16). Previous reports of mutagenesis at residue 166 did not include the E166H 
and E166Y mutations (36). The activity of these unexpected functional mutations leads to 
a greater understanding of the structural requirements of catalysis. Thus, site-saturation 
mutagenesis has assumed an important role in our lab's investigations of 13-lactamase 
activity. 
Early crystallographic studies identified a number of residues in the area of the 
active site. Our lab has studied a number of these sites, including Lys 73 and Glu 166. 
Computer modeling of the active site indicated a possible mode of binding for the 13-
lactam substrate, as well as the catalytic functions of certain residues (17). As stated 
above, the carboxylate side chain of Glu 166 was implicated as a general base in the 
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deacylation step of enzyme catalysis (Figure 14). Mutagenesis studies support this 
hypothesis, and also helps to define the structural requirements for catalysis. The 
conservative mutation E166D is functional, with KM nearly identical to wild-type, but 
kcat down by -2 orders of magnitude. The pH studies show catalytic behavior similar to 
wild-type. This illustrates that the residue is important for catalysis, but probably not 
directly involved in formation of the ES complex. The removal of one CH2 unit in the 
E166D mutant shortens the side chain by -1A, thereby pulling the carboxylate 
functionality away from the substrate (as acyl-enzyme) and the water implicated in 
deacylation. This explains the reduction in rate. 
The mutation E166H also gives a functional enzyme, with kinetic parameters 
comparable to the E166D mutant. It would appear that the active site environment around 
the 166 residue is such that the imidazole side chain of histidine is deprotonated, and can 
thus also function as a general base. However it is difficult to determine if the rate 
decrease is a function of different basicities, geometry changes, or a combination of the 
two. Another factor concerns the formation of a positive charge on the imidazole upon 
protonation. This charge could be somewhat undesirable in that particular area of the 
active site, and could act to raise the pKa. therefore decreasing the rate. 
Attempts were made to study the catalytic behavior of the E166Y mutant. 
Unfortunately, this enzyme did not seem to obey Michaelis-Menten kinetics. It is possible 
to envision an altered mechanism for this mutation, where the phenolic side chain of the 
tyrosine is deprotonated. This anion could function as a base, but it could also function as 
a nucleophile, directly attacking the acyl-enzyme intermediate, giving a second acyl-
enzyme intermediate (Figure 15). This second intermediate would then need to be 
hydrolyzed for enzyme turnover. The nucleophilicity of phenoxide is rather high, with an 
value of 3.5, equivalent to Br- (37), and the leaving group ability of the phenolic group 
(Tyr 166) is greater than that of the hydroxyl (Ser 70)(38). This more complex 
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Figure 15. Possible mechanism for deacylation reaction for E166Y mutant. 
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mechanism would be slower, but could be facile enough to confer phenotypic resistance. 
The details of the acylation step in ~-lactamase catalyzed hydrolysis are still not 
well understood. It has been suggested that Lys 73 is a key player in the kinetic scheme, 
either directly as a general base, or indirectly by electrostatic interactions (Figure 
16)(refs). Site saturation mutagenesis studies unfortunately do not shed much light on this 
dilemma. It is obvious that no other amino acid at position 73 gives functional enzyme. 
Yet some generalizations can be suggested. If Lys 73 were interacting solely by 
electrostatics, it would be expected that the mutant K73R would have some activity, as 
this side chain is positively charged. The geometry differences between the two could 
cause some problems, but since electrostatic interactions are basically non-directional, it 
would be expected that the Arg side chain would give an enzyme with some activity. 
The fact that other amino acids known to function as general bases (His, Asp, 
Glu) similarly give inactive enzyme would seem to suggest that the function of Lys 73 is 
not basic in nature. However this hypothesis overlooks geometric concerns. None of the 
other basic side chains would extend into the active site cleft like Lys. Therefore, the 
mutant basic side chains would be fairly far removed from the correct position and 
orientation for proton abstraction. The lack of active combinatorial mutants indicates that 
there can be no compensation for the loss of amine functionality by residue 166, and it 
appears that the reasons are primarily geometric in nature. 
There is no way to generate a mutant at site 73 that positions a basic side chain far 
enough into the active site, save mutagenesis using unnatural amino acids or chemical 
modification techniques (Figure 17). These experiments could indicate the function of 
Lys 73. For instance, if an amino acid with a butanioc side chain could be inserted, the 
carboxylate should be closer to the correct position for proton abstraction. Similarly, 
chemical modification of the K73C mutant could also give a mutant with a potential base 
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Figure 17. Possible scheme for changing functional group at residue 73. 
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the pKa necessary to do the job. For instance a carboxylate may not be basic enough to 
deprotonate the water; it may be that an amine is the optimal functional group 
considering the surrounding environment. The next chapter discusses what could be the 
definitive experiment to determine the pKa of Lys 73, and the probable function of this 
conserved active site residue. 
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Chapter 4 
Attempts to Determine the pKa of an Active Site Residue in RlEM-1 J3-lactamase via 
Site-Directed Mutagenesis, Chemical Modification, and NMR Spectroscopy 
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INTRODUCTION 
The class A ~-lactamases all have a molecular weight around 30 kilodaltons and 
catalyze ~-lactam cleavage which confers bacterial resistance to cephem and penam 
antibiotics (Figure 1)(1). This class includes the RTEM-1 ~-lactamase of E. coli (2), 
Staphylococcus aureus PCI (3), Bacillus licheniformis 749/C (4), and Bacillus cereus 
569/HI(5). Sequence homologies between members of this class are considerable, ranging 
from 26 to 65 % (6). The class B ~-lactamases consist of only two enzymes, from B. 
cereus and Proteus maltophilia, and differ considerable from the class A enzymes in 
molecular weight and catalytic mechanism. These enzymes, which contain a metalloenzyme 
complex with either zinc(II) or cobalt (III) at the catalytic center, appear to function as 
general base catalysts, with no indication of an acyl-enzyme intermediate formation during 
the hydrolysis (7). The third ~-lactamase class, the class C enzymes, consist of the largest 
enzymes and utilize a nucleophilic serine in the active site (8). Both the class B and C ~­
lactarnase preferentially hydrolyze cephems. 
The class A and class C ~-lactamases attack the ~-lactam of penam and cephem 
antibiotics through a nucleophilic serine, in a mechanism similar to that of the penicillin 
binding proteins (Figure 2). A class A ~-lactamase of particular interest is the RTEM-1 
enzyme from E. coli (9). This enzyme has been extensively studied, in part due to its 
availability as a resistance marker on the ubiquitous plasmid pBR322. RTEM-1 is a soluble 
protein of 28.5 kD. It is synthesized as a 286 amino acid preprotein, with a 23 residue 
leader sequence cleaved off during export of the protein into the peri plasm of the cell. The 
RTEM -1 enzyme has been used in the examination of protein secretion (I 0), expression of 
fusion proteins (11), and as a selectable marker (12). Like most class A ~-lactamases, 
RTEM-1 preferentially hydrolyze penam antibiotics at rates approaching evolutionary 
perfection. The apparent second-order rate constant, kcatiKM. is on the order of 108 M-ls-
1, nearly the rate of a diffusion controlled mechanism. 
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benzyl penicillin cephalothin 
Figure 1. Representative ~-lactam antibiotics. Benzyl penicillin is a member 
of the penam family, cephalothin is a cephem. Arrow points to bond 














Figure 2. Overall reaction catalyzed by ~-lactamase 
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Though the overall mechanism of ~-lactamase activity is understood, the role of 
many specific residues has not been well characterized. A detailed understanding of the 
catalytic mechanism of these enzymes would not only further the understanding of the 
structure/function relationships of enzymatic processes in general, but would also aid in the 
rational design of new antibiotics. 
To date the most elusive aspect of the detailed mechanism of action of ~-lactamase is 
the nature of activation of the active site serine hydroxyl. Figure 3 shows the arrangement 
of residues in the active site. It has been assumed that a proton shuttle mechanism akin to 
the serine proteases is at work in the active site of ~-lactamase. An alternative explanation 
was put forth by Hertzberg et al. with the publication of their crystal structure (13). The 
authors implicated Lys 73 as influencing Ser 70, but through electrostatic assistance of the 
Lys 73 positively charged ammonium group. An alternate explanation was suggested by 
Strynadka et al. in a paper describing the crystal structure of the acyl-enzyme intermediate 
of a deacylation defective mutant (14). These authors predicted that Lys 73 functioned as a 
general base, removing the proton from Ser 70, thus increasing its nucleophilicity (Figure 
4). For this to be plausible, the pKa of Lys 73 would have to be depressed approximately 
three to four pH units from the typical pKa of - 10. This is not unheard-of, as pKa's of 
lysine side chains in proteins have been measured as low as 5.9 (15). Unfortunately, 
normal crystal structure analysis does not give information about protons, so no further 
evidence for this mode of action was available. 
In order to test this hypothesis, the pKa of Lys 73 would need to be determined 
some way. Mutagenesis experiments in our laboratories showed that any changes at 
position 73 resulted in severely impaired enzyme. Further, the mutation K73C gave 
enzyme that was down -104 from wild-type (16). However, upon reaction with 
ethyleneimine , activity of the K73C mutant was restored to near wild-type levels (17). The 
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Figure 4. Formation of acyl-enzyme intermediate with Lys 73 
functioning as a general base. 
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position 73, which effective mimics the native lysine side chain, save the change of a single 
carbon to a sulfur atom (Figure 5). This result suggested an experiment where in the K73e 
mutant could be reacted with an amino ethylating reagent containing a stable isotope which 
would permit NMR studies in spite of ~-lactamases size (Figure 6). Both 15N and Be 
nuclei could be incorporated into a labeling molecule (Figures 7 and 8), and the pKa of the 
resulting aminoethylcysteine could be determined by an NMR titration experiment. 
The chemical shift of NMR active nuclei can shift when influenced by changes in 
charge and/or protonation on adjacent atoms. Specifically, a 15N atom's chemical shift 
changes by -7 ppm upon protonation of the neutral amine (Figure 9)(18). Similarly, a Be 
nuclei ~ to an amine undergoes an -6 ppm shift upon protonation of the amine (Figure 
10)(19). The a-carbon shift is much less pronounced. These shifts theoretically could be 
followed by taking spectra at a variety of pH's, and a pKa extracted from the data. 
Indirect detection NMR methods can also be used to examine the ionization of 
residue 73. These so called Heteronuclear Multiple Nuclear Coherence (HMQe) 
experiments are advantageous in that the 1 H nuclei is being detected, rather than Be and 
15N, which have much lower sensitivities than proton (20). The experiment also enables 
one to look only at protons which are bonded to Be (or 15N) heteronuclei (21). Thus the 
lion share of the proton signals from the enzyme are edited out, and only very specific 
protons are seen in the case of the above mentioned labeling experiments. Thus lower 
concentrations of protein can be used, avoiding potential solubility and related problems. 
Using any of these experimental approaches, the pKa of the native Lys 73 amine 
side chain could be inferred from the experimental pKa of the aminoethylcysteine side 
chain, which is -1 pKa unit lower than lysine (22). The presence of a depressed pKa ( -7 or 
8) in the aminoethylated enzyme would indicate that Lys 73 could indeed function as a 
general base, activating Ser 70. 
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Figure 5. Reaction of inactive K73C mutant with ethyleneimine restores activity. 
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Figure 9. Plot of chemical shift vs. pH for 15N in lysine. 
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Figure 10. 13C chemical shifts at different pH's for lysine. 
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MATERIALS AND METHODS 
Enzymes and chemicals. 15N-potassium phthalimide and (l)-13C-glycine were 
obtained from Cambridge Isotope Laboratories. Other reagents were from Aldrich 
Chemical Company. NMR spectra were taken on GE 300 Mhz, Broker AMX-500, and 
Varian 600 Mhz spectrometers. Media was from Difco Laboratories. FPLC equipment and 
columns were from Pharmacia. Enzymes were purchased from Boehringer Mannheim 
Biochemicals, New England Biolabs, and Promega. Antibiotics were from Sigma. 
Radioactive compounds were supplied by Amersham. Isopropyl-13-thiogalactoside (IPTG) 
was from International Biotechnologies Inc. (IBI). Molecular biology grade reagents 
agarose, acrylamide, phenol, chloroform, ammonium persulfate were from Bio Rad. 
Bacterial Strains. Escherichia coli were used in all experiments. Plasmid DNA was 
grown in strain D1210 (23); the pJN expression vector was grown in strain D1210, which 
is lac iQ. Culture media was L broth unless otherwise indicated. Cells were made 
competent for transformation of plasmid DNA using a process adapted from Hanahan (24). 
Synthesis of 15N-bromoethylamine hydrobromide. 
2-bromoethyltosylate. This procedure is adapted from Organic Syntheses (25). In a 
typical experiment, bromoethanol (Aldrich) and p-toluenesulfonylchloride (Aldrich) in a 
2: 1 molar ratio was combined in pyridine, and left at 4 °C overnight. The formation of 
pyridine hydrochloride is evidenced by the presence of white crystals at the bottom of the 
flask. The entire mixture is added to cold H20, and the 2-bromoethyltosylate separates as 
an oil. The oil is taken up in diethyl ether, and the aqueous layer extracted with diethyl 
ether. The combined organic layers are washed with cold aqueous HCl, then dried over 
MgS04. Upon evaporation, a yellow oil is isolated. 
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15N-2-bromoethylphthalimide. Two different methods were employed for the 
synthesis of 15N-2-bromoethylphthalimide. The first is a modification of the Gabriel 
synthesis (26) put forth by Brown and van Gulick (27). The Gabriel synthesis of primary 
amines uses potassium phthalimide and an alkyl halide, condensing to form an 
alkyphthalimide, which is hydrolyzed under acidic conditions to the primary amine acid 
salt. For the synthesis of 15N-2-bromoethylphthalimide, 15N-potassium phthalimide is 
added to excess 1,2-d.ibromoethane in dimethylformamide. This is heated to 90°C for 1 
hour, and the solvent removed under reduced pressure. The residue is taken up in water, 
and extracted with CH2Cl2. The combined organic layers are dried over MgS04, filtered, 
and the solvent removed under reduced pressure. The resulting residue is triturated in 
petroleum ether, and dried in vacuo. In an effort to increase the yield, 2-bromoethyltosylate 
was tried as an alkylating reagent, as the tosylate functionality is a much better leaving 
group that bromide. Equimolar amounts of 15N-potassium phthalimide and 2-
bromoethyltosylate were combined in dimethylformamide, and heated to 90° C for 1 hour. 
Water was added, followed by extraction with diethyl ether. The combined organic layers 
were dried over MgS04, filtered, and solvent removed in vacuo, giving white crystals of 
15N-2-bromoethylphthalimide . 
15N-2-bromoethylamine hydrobromide. 15N-2-bromoethylphthalimide was added 
to HBr in acetic acid and water, and refluxed for 9 hours. The solution was chilled, and 
solidified phthalic acid was removed by filtration. The filtrate was evaporated in vacuo, and 
the product crystallized from acetone to give 15N-2-bromoethylamine hydrobromide. 
Synthesis of 13C-bromoethylamine hydrobromide. 
13c-BOC-glycine. Synthesized according to the procedure set forth by Itoh et al. 
(28). 13C-glycine, 2-(tert-butoxycarbonyloxyimine)-2-phenylacetonitrile (BOC-ON), and 
neat triethylamine were combined in 1: 1 Dioxane:water and stirred at room temperature for 
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2 hours. Then water and ethyl acetate were added, and the organic layer discarded. The 
aqueous layer was washed with ethyl acetate. The aqueous layer was then acidified by the 
addition of 10% citric acid, and extracted with diethyl ether. The combined organic 
fractions were dried over MgS04, filtered, and the solvent removed in vacuo, giving Be_ 
BOC-glycine . 
13 C -BOC -ethanolamine. The reduction of 13C-BOC-glycine to Be_ HOC-
ethanolamine was accomplished by the use of the borane reagent BH3-THF (29). 13C-
BOC-glycine was added to dry THF in a 3-necked round bottom flask. The resulting 
solution was chilled to 0°C, and 1M BH3-THF was added over 20 minutes from a 
separatory funnel. The resulting mixture was removed from the ice bath, allowed to come 
to room temperature, then stirred for 5 hours. The mixture was again chilled to 0°C, and 
1.5N NaOH was added over 20 minutes. The resulting mixture was allowed to come to 
room temperature, and stirred overnight. The solution was saturated with solid K2C03, 
and extracted with diethyl ether. The combined organic fractions were dried over MgS04, 
filtered, and solvent removed in vacuo. 
13 C -2-bromoethylamine hydrobromide. Synthesis of 13C-2-bromoethylamine 
hydrobromide was based on the modifications of Wystrach of the original Organic 
Synthesis Prep (30, 31). Concentrated HBr (48% HBr) was added slowly to 13C-BOC-
ethanolamine . The resulting mixture was heated until water began to distill at 1 00°C. The 
boiling point raised to 122°C, and aqueous HBr was collected. Heating was continued 
until no more HBr distilled. The pot temperature was never allowed to rise above 140°C. 
The residue was chilled to below 100°C, and acetone was added with stirring. The mixture 
was left at -20°C for 3 hours, and resulting solid 13C-2-bromoethylamine hydrobromide 
was collected by filtration. 
K73C 13-lactamase. 
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DNA. Oligonucleotides were synthesized by the Caltech Microchemical Facility using 
phosphoramidite chemistry (32) on an Applied Biosystems automated DNA synthesizer 
380A. Degenerate oligonucleotides were made equimolar in A, C, G, and T at positions 1 
and 2 of the codon, and inC and Gat position 3. These oligonucleotides were purified by 
preparative polyacrylamide gel electrophoresis. 
Wild-type plasmid pBR322 and bacteriophage M13 mp18 replicative form (RF) DNA 
were purchased from Bethesda Research Laboratories. Mutant plasmids and RF phage 
were purified from E. coli by alkaline lysis method (33, 34). Single-stranded phage DNA 
was prepared from phage supernatant by precipitation with 20% polyethylene glycol-
6000/2.5 M NaCl (35) followed by phenoVchloroform extraction and ethanol precipitation. 
Restriction digest typically used 10-20 J.lg plasmid DNA, 2-5 units of restriction 
enzyme, and 2 J.ll lOX digest buffer in 20 J.ll at 37°C for 1-2 hours. DNA restriction 
fragments were run in 1.2% low melt agarose gels, visualized with ethidium bromide, and 
isolated by established procedures (34 ). 
Mutagenesis. Cassette mutagenesis is a technique wherein mutations can be introduced 
into a gene of interest using complementary synthetic oligonucleotides in conduction with 
restriction endonucleases, followed by ligation. Providing convenient restriction site are 
available in the gene, mutagenesis of one or more residues can be accomplished with out 
the use of a single stranded vector or subcloning routines. 
The site saturation of residue 73 was accomplished previously by Steve S. Carroll in 
our laboratories (18). Briefly, complementary synthetic oligonucleotides containing a 
degenerate codon at residue 73 and overhangs corresponding to Ava I and Sea I sites were 
kinased and annealed by standard procedures (34). Plasmid pBR-CR7 (39) was digested 
with Sea I and Sal I, and the 3286 bp fragment was isolated from a low melt agarose gel 
(34) . Plasmid pBR322-XNl (18) was digested with Ava I and Sal I, and the 1042 bp 
fragment isolated from a low melt agarose gel. These two fragments were mixed in 
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equimolar concentrations with a five-fold excess of the synthetic cassette insert, and ligated 
by standard procedures (34). 10 Ill of this ligation mixture were transfected directly into 
competent E coli. strain HB 101 and cells were spread onto L plates containing 15mg!l 
tetracycline. The plasmid DNA was isolated by alkaline lysis, and subjected to restriction 
analysis and sequencing. 
DNA Sequencing. Plasmid DNA was sequenced using a modification of the 
Sanger dideoxy method for denatured, double-stranded DNA (36). Plasmid DNA together 
with sequencing primer was boiled for 5 minutes, then snap frozen in dry ice/ethanol. 
Chain extension reactions were performed with a SEQUENASE™ kit from United States 
Biochemical (37). Radioactive labeling was accomplished with a-35S-dATP. Labeled DNA 
was separated on 8% polyacrylamide sequencing gels, and resulting gels were dried in 
vacuo. Kodak AR x-ray f:tlm was then exposed in the presence of the sequencing gel for 12 
hours . 
Protein Expression and Purification. To facilitate expression, the mutant 13-lactamases 
were subcloned into pJN, and expression vector which was developed in this lab (38). It 
contains the 13-lactamase gene under control of the tac promoter (39), and well as a 
kanamycin gene for a selection marker. Synthesis of 13-lactamase is induced by the addition 
of IPTG. 
Twelve liter cultures of E.coli D1210 containing mutant plasmid were grown in TB 
broth (25 g Tryptone, 25 g yeast extract, 3 ml glycerol, 100 mls 1 M phosphate pH 8 per 
liter of broth) containing 50 mg/L kanamycin for 12-14 hours at 37°C. IPTG was added to 
a final concentration of 0.1 mM and growth continued for 2 hours at 37°C. Cells were 
centrifuged in 1 1 bottles in a rotor for 30 minutes at 4,000 rpm. 13-lactamase, which is 
located in the periplasm, was released by osmotic extrusion (40). The sample containing 
the perplasmic proteins made 25 roM TEA pH 7.3 by the addition of 1M TEA pH 7.3, and 
added to- 150 mls of MonoQ fast Flow resin. This mixture was stirred at 4°C for 1 hour, 
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and applied to an empty gravity column. The resulting resin was washed further with - 200 
mls of 25 mM TEA pH 7.3. The protein was eluted with 200 mM NaCl in 25 mM TEA pH 
7.3 (-200 mls). This solution was dialyzed and concentrated to- 30 mls in 25 mM TEA 
pH 7.3 (Buffer A) by ultrafiltration (Amicon unit, YM 10 membrane, N2 gas pressure). 
The resulting solution was then filtered through a Schleicher and Schuell 0.22 m U niflow 
filter to remove any cellular debris. 
Further purification was carried out using FPLC (fast protein liquid chromatography) 
first with a HR16/10 Fast Flow MonoQ™ column, followed by a HR10/10 MonoQ™, 
both by Pharmacia. Crude protein was loaded onto the fast flow column, and the column 
was washed in 100% A (25 mM triethanolamine (TEA), pH 7.65). Then crude 13-lactamase 
was eluted with 20%B (25 mM TEA, 1M NaCl). This protein was loaded onto the HR 
10/10 column in 25 mM TEA and eluted with a salt gradient. The gradient used was: t=O, 
100% A, t=5, 100% A, t=35, 80%A, 20%B, t=45, 100% B. The flow rate was 1.0 
ml/min. Elution was monitored by A280· Peak fractions were pooled and dialyzed versus 
100 mM potassium phosphate, pH 7 .0. Protein concentrations were estimated from OD280 
using an extinction coefficient of 29,400 M-lcm-1(2). Samples were run on 15% 
polyacrylamide gels (34) and stained with Coomasie blue to gauge purity. 
Aminoethylation of K73C /3-Iactamase. Purified K73C 13-lactamase was dialyzed 
into 500 mM sodium phosphate, pH 8.4 by ultrafiltration (Amicon unit, YM10 membrane). 
Two labeling conditions were employed. The first involved partial denaturation of the 
protein by addition of solid urea to a final concentration of 4.0 M urea. To this was added 
sufficient labeled 2-bromoethylamine hydrobromide to a final concentration of 100 mM. 
This solution was left at room temperature overnight. A five-fold excess of 500 mM 
phosphate pH 8.4/4.0 M urea was added to the solution, and this was dialyzed against 50 
mM phosphate pH 7.0 (dialysis tubing MW cutoff 8000). Alternatively, the protein in 
pH 8.4 phosphate buffer was made 100 mM in 2-bromoethylamine hydrobromide by 
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addition of solid compound, and this solution left at 37°C overnight. This solution was 
diluted five-fold with 500 mM phosphate pH 8.4, and dialyzed against 50 mM phosphate 
pH 7.0 (dialysis tubing MW cutoff 8000). 
Kinetic Characterization of K73AEC {3-lactamase. Michaelis-Menten kinetic 
parameters (kcat• K M• and kcat!K M) for mutant f3-lactamases were determined by Hanes 
plots using initial rates (41). Reactions were carried out at 30°C in 100 mM potassium 
phosphate pH 7 .0. All reagent were maintained at 30°C prior to beginning the assay to 
avoid error from temperature flux. An HP 8420 spectrophotometer was used for the 
assays, with quartz cells of pathlength 1 em at wavelength 232 nm. 
1 H NMR Spectroscopy. Proton spectra for small molecules was performed on a 
GE-300 QE plus NMR spectrometer. Typical parameters are: 
Pulse Width = 4.75 JlSec @ 43 degrees 
Acquisition Time = 2.72 seconds 
Recycle Time = 3.71 seconds 
Line Broadening = OHz 
Spin rate = 23 rps 
Observe Frequency = 300.199850 MHz 
Spectral Width = 6024Hz 
15N NMR Spectroscopy. 15N spectra were taken on a Bruker AMX-500 NMR 
































13c NMR Spectroscopy. Be spectra were taken on aGE 300 QE plus NMR 































HMQC NMR Experiment. The HMQe sequence can be reduced to a heteronuclear 
spin-echo difference experiment as illustrated in Figure 11. The proton portion of this 
sequence consists of a simple spin-echo experiment with the phase of the receiver alternated 
from scan to scan. For protons attached to 12e (X= Be), for which the lH pulses are the 
only relevant pulses, the signal remains in constant phase from scan to scan--alternation of 
the receiver causes these signals to cancel. On the first scan, the Be nuclei experience a 
180° pulse (90°x + 90°x) simultaneously with the 1H 180°. Because this occurs at a time 
equal to 1/2JxH. the signal that results from this scan refocuses on the +y axis. On the 
second scan, the Be nuclei effectively experience no pulse at all (90° x + 90° -x) so the 
protons refocus on the-y axis, but the receiver is now inverted so the net signal is positive. 
Thus, the protons attached to Be have produced a positive signal on both scans, so the 
signal from these protons time-averages at the same time that the signals from the I2e-
bound protons cancel out. 
RESULTS 
Synthesis of l.5.N-2-bromoethylamine hydrobromide. 
2-bromoethy/tosy/ate. In a typical experiment, 80 mmol (10 g) of 2-bromoethanol 
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Figure 11. Pulse sequence for HMQC heteronuclear spin-echo difference experiment. 
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pyridine in a 250 ml Erlenmeyer flask, and left at 4 oc overnight. The formation of pyridine 
hydrochloride is evidenced by the presence of white crystals at the bottom of the flask. The 
entire mixture is added to -300 ml of cold water, and the 2-bromoethyltosylate separates as 
an oil. The oil is taken up in diethyl ether, and the aqueous layer extracted two times with 
diethyl ether. The combined organic layers are washed with cold aqueous HCl two times, 
then dried over MgS04. Upon evaporation, a yellow oil is isolated, yield 21.3 g (90%). 
15N-2-bromoethylphthalimide. Two different methods were employed for the 
synthesis of ISN-2-bromoethylphthalimide. The Gabriel synthesis of primary amines uses 
potassium phthalimide and an alkyl halide, condensing to form an alkyphthalimide, which 
is hydrolyzed under acidic conditions to the primary amine acid salt. For the synthesis of 
ISN-2-bromoethylphthalimide, 5.4 mmol ISN-potassium phthalimide (1.0 g, Cambridge 
Isotope Laboratories) is added to 16.1 mmol 1,2-dibromoethane (3.0 g, Aldrich) in 5.2 ml 
dimethylforrnamide. This is heated to 90°C for 1 hour, and the solvent removed under 
reduced pressure. The residue is taken up in 6 mls water, and extracted three times with 6 
mls CH2Cl2. The combined organic layers are dried over MgS04, filtered, and the solvent 
removed under reduced pressure. The resulting residue is triturated in 6 mls petroleum 
ether, and dried in vacuo. Yield of 15N-2-bromoethylphthalimide is 3.6 mmol (0.93g, 
67%). In an effort to increase the yield, 2-bromoethyltosylate was tried as an alkylating 
reagent, as the tosylate functionality is a much better leaving group that bromide. 5 mmol 
15N-potassium phthalimide (0.93 g) and 5 mmol 2-bromoethyltosylate (1.40 g) were 
combined in 10 ml dimethylforrnamide, and heated to 90° C for 1 hour. 10 mls of water 
was added, followed by extraction with two times 20 ml diethyl ether. The combined 
organic layers were dried over MgS04, filtered, and solvent removed in vacuo, giving 
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Figure 12. lH NMR spectra of lSN-2-bromoethylphthalimide. 
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15N-2-bromoethylamine hydrobromide. 15N-2-bromoethylphthalimide (2.5 g, 10 
mmol) was added to 15 mls HBr in acetic acid and 5 ml water. This mixture was refluxed 
for 9 hours. The solution was chilled, and solidified phthalic acid was removed by 
filtration. The filtrate was evaporated in vacuo, and the product crystallized from acetone to 
give 0.93 g (45% yield) 15N-2-bromoethylamine hydrobromide (lH NMR Figure 13) 
Synthesis of 13.C-2-bromoethylamine hydrobromide. 
13C-BOC-glycine. 13C-glycine (0.75g, 10 mmol), 2-(tert-
butoxycarbonyloxyimine)-2-phenylacetonitrile (BOC-ON, 2.7g, 11 mmol), and 2.8 mls 
neat triethylamine were combined in 12 mls of 1:1 dioxane:water and stirred at room 
temperature for 2 hours. Then 15 mls water and 20 mls ethyl acetate were added, and the 
organic layer discarded. The aqueous layer was washed with 20 mls ethyl acetate. The 
aqueous layer was then acidified by the addition of 10% citric acid, and extracted five times 
with 15 mls diethyl ether. The combined organic fractions were dried over MgS04, 
filtered, and the solvent removed in vacuo, giving 1.53g 13C-BOC-glycine (87%, lH 
NMR Figure 14, Be NMR Figure 15). 
l3C-BOC-ethanolamine. The reduction of 13C-BOC-glycine to 13C-BOC-
ethanolamine was accomplished by the use of the borane reagent BH3-THF. 1.75g 13C-
BOC-glycine (10 mmol) was added to 3 mls dry THF in a 50 mls 3-necked round bottom 
flask. The resulting solution was chilled to 0°C, and 20 mls 1M BH3-THF (20 mmol) was 
added over 20 minutes from a separatory funnel. The resulting mixture was removed from 
the ice bath, allowed to come to room temperature, then stirred for 5 hours. The mixture 
was again chilled to 0°C, and 6 mls 1.5N NaOH was added over 20 minutes. The resulting 
mixture was allowed to come to room temperature, and stirred overnight. the solution was 
saturated with solid K2C03, and extracted with 10 mls diethyl ether five times. The 
combined organic fractions were dried over MgS04, filtered, and solvent removed. 
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Figure 13. lH NMR spectra of lSN-2-bromoethylamine hydrobromide. 
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Figure 14. lH NMR spectra of 13C-BOC-glycine. Solvent is d{;-DMSO. 
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Figure 15. Be NMR spectra of 13C-BOC-glycine. Solvent is d{j-DMSO. 
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Yield of 13C-BOC-ethanolamine was 1.29 g (78%, lH NMR Figure 16, 13C NMR Figure 
17). 
13C-2-bromoethylamine hydrobromide. Synthesis of 13C-2-bromoethylamine 
hydrobromide was based on the modifications of X of the original Organic Synthesis Prep. 
5.2 mls concentrated HBr (48% HBr, 36 mmol) was added slowly to 2.32 g 13C-BOC-
ethanolamine (14.5 mmol). The resulting mixture was heated until water began to distill at 
100°C. The boiling point increased to 122°C, and aqueous HBr was collected. Heating 
was continued until no more HBr distilled. The pot temperature was never allowed to rise 
above 140°C. The residue was chilled to below 100°C, and 3 mls acetone was added with 
stirring. The mixture was left at -20°C for 3 hours, and resulting solid 13C-2-
bromoethylamine hydrobromide was collected by filtration (l.lOg, 37% yield, lH NMR 
Figure 18, Be NMR Figure 19) 
Expression and Purification of K73C mutant. Twelve liters of media with proper 
antibiotic were grown to saturation at 37°C. IPTG was added (24 mg/1) and incubation 
continued for I hour. After dialysis into Buffer A and concentration by Amicon, ~­
lactamase was purified on a Mono Q column by FPLC (Figure 20). Fractions containing ~­
lactamase were identified by PAGE (Figure 21). 
Aminoethylation of K73C mutant. Early attempts to label the K73C mutant were 
plagued by renaturation difficulties. Test labeling reaction with a small amount of enzyme 
was successful, but upon scale up to amounts necessary for NMR experiments, protein 
precipitated upon refolding and dialysis into the pH 7.0 buffer. Initial conditions were 
worked out by Steve S. Carroll in our labs (18), but these conditions proved unsatisfactory 
for larger amounts of protein. So modifications of his original protocol were made, 
switching from Tris as a buffer, to phosphate. Also, dilution of the labeling solutions prior 
to dialysis was found to be helpful. Up to 30 mg of protein was labeled in 4 mls of labeling 
solution, split between 4.0 M urea conditions and 3rC conditions. Upon dilution and 
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Figure 16. lH NMR spectra of 13C-BOC-ethanolamine. Solvent is ci6-DMSO. 
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Figure 18. lH NMR spectra of 13C-2-bromoethyamine hydrobromide. Solvent is D20. 
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Figure 21. PAGE ofFPLC fractions for K73C mutant. ~-lactamase is in fraction 7. 
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dialysis eventually into 50 mM phosphate, enzyme was isolated, with activity analyzed by 
kinetic studies, and purity assayed by PAGE. Enzyme was found to be homogeneous 
before and after labeling (data not shown). 
Activity of K73AEC mutant. The activity of the labeled mutant was checked by 
kinetic analysis under standard conditions. The highest level of activity was found to be 
-50% that of wild-type, and activity before and after labeling was assayed (Figure 22). 
15N-Titration of K73AEC. Labeled protein was added to a 10 ml NMR tube in 
-50% D20, 25 mM phosphate pH 7.0 at a concentration of -20 mg/ml. At this 
concentration, protein slowly precipitated out of solution, indicating that this is the upper 
limit of [3-lactamase solubility. Repeated attempts to see an 15N signal were unsuccessful. A 
variety of pulse delay times were tried to allow for long relaxation times, but experiments 
involving upwards of 20,000 scans still revealed no 15N signal (Figure 23). 
13C-Titration of K73AEC. A 13C spectra of aminoethylcysteine (Aldrich) was 
taken to ascertain where the 13C nuclei of the carbons a- and [3- to the amine would be. It 
was determined that these two carbons had a chemical shift of 37 ppm and 27 ppm (Figure 
24). Labeled protein was added to a 5 ml NMR tube in -50% D20, 25 mM phosphate pH 
7.0 at a concentration of -10 mg/ml. A small amount of d6-DMSO was used as a 13C 
reference. The initial experiment with a delay time of 1 second and 18,000 scans revealed 
no Be peak other than the DMSO reference. Another experiment was run on the same 
sample with an increased delay time of 2 seconds. This gave what appeared to be a small 
single peak at 30 ppm, but was determined to be an artifact. The protein concentration was 
increased to 20 mg/ml, but still no Be signal for the protein was seen (Figure 25). 
HMQC NMR Experiment. To determine the correct parameters for the spin-echo 
experiment, 13C-2-bromoethylamine hydrobromide was used in model experiments. Figure 
26 shows the results of these experiments. The bottom spectra is a lH spectra for 13C-2-
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Figure 22. Plot of absorbance vs. time for hydrolysis of benzyl penicillin catalyzed by 
K73C before and after labeling with 13C-2-bromoethylamine hydrobromide. 
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Figure 26. HMQC experiment for 13C-2-bromoethylamine hydrobromide. Bottom, lH 
spectra of 13C-BEA. Middle, 13C-edited spectra. Top, 13C-editedfl3C-1H decoupled 
spectra. 
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top is the Be edited IH spectra decoupled. Next, the Be labeled !3-lactamase was run, 
with the unedited protein I H spectra shown in Figure 27. This sample was then subjected 
to spin-echo experiments giving a 13C edited spectra (Figure 28). The spectra showed a 
large number of peaks. This suggested a couple of possibilities; the sample had impurity 
proteins which were labeled under the labeling conditions, 13-lactamase was not labeled at 
only one site, and/or the experimental parameters were not correct for editing. To assay the 
latter two possibilities, wild-type 13-lactamase was subjected to labeling with 13C-2-
bromoethylamine hydrobromide under both standard conditions (4 M urea, and 37° C). The 
results of this control experiment are shown in Figure 29. The NMR parameters appear to 
be correct, as the editing is successful; only one other peak is seen, either from another 
residue or n-terminus being modified, or perhaps an artifact from incomplete dialysis. The 
Be labeled K73C 13-lactamase was rechromatographed by FPLC, and indeed impurities 
were seen. 
This rechromatographed sample was subjected to the HMQC experiment, with the 
results shown in figures 30 and 31. Figure 30 shows the unedited spectra (bottom), and the 
Be-edited spectra (top). A clean broad singlet is seen in the Be-edited spectra at -2.7 ppm 
(referenced to water @ 4.8 ppm), which is not apparent in the I H spectra. When 
referencing these spectra to the labeled wild type control, it seems that this peak is not an 
artifact, and could be the peak of interest (Figure 31). Unfortunately, the sample had 
degraded over time and repeated purification's, and the pH behavior of this peak could not 
be assayed (the spectra were obtained over 60 hours of acquisition time). Efforts are 
underway to analyze new samples. 
DISCUSSION 
The first requirement for all of these NMR experiments is a large amount of protein. 
The pJN expression vector gives -1 mg/L of growth. Therefore, rather large protein preps 
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Figure 27. lH spectra of 13C-K73AEC 13-lactamase. Bottom, lH spectra. Top, 13C-edited. 
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Figure 28. HMQC experiment on 13C-K73AEC !3-lactamase. Bottom, lH spectra. Top, 
13C-edited spectra. 
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Figure 29. HMQe control experiment on Be-wild type J3-lactamase. Bottom, Be-edited 
spectra of 13e-K73AEe. Middle, Be-edited spectra of wild type 13-lactamase labeled@ 
37°. Top, Be-edited spectra of wild type 13-lactamase labeled under urea conditions. 
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Figure 30. HMQC experiment on repurified 13C-K73AEC ~-lactamase. Bottom, lH 
spectra. Top, Be-edited spectra. 
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Figure 31. HMQC experiment on 13C-K73AEC ~-lactamase. Bottom, Be-edited spectra of 
repurified 13C-K73AEC. Middle, 13C-edited spectra of wild type control using urea. Top, 
13C-edited spectra of wild type control@ 37°. 
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are required to give the tens of milligrams of 13-lactamase required. Large-scale 
fermentations could be used, but the osmotic extrusion procedure does not work well when 
scaled up. All of these factors would indicate the requirement of a more efficient expression 
system. 
Other members of our group have had success with the T7 expression system from 
Novagen. C. Stutter in our group has achieved yields of up to 40 mg/L of culture using this 
system (42). This system would appear to be ideal for the large amounts of protein required 
for these NMR experiments, so insertion of the K73C 13-lactamase gene into the pET 
system was attempted. Briefly, PCR was used to create proper restriction sites flanking the 
K73C mutant gene, with the PCR product digested and ligated into the pET vector. 
Unfortunately, repeated attempts at protein expression resulted in the build up of large 
amounts of the preprotein in the cytoplasm, with almost no processing and secretion into 
the periplasm. One possible problem is that the expression system is so good, it 
overpowers the cellular processing system. Another potential problem lies in the mutation 
K73C. Other groups have reported seeing similar expression problems with Ser to Cys 
mutated proteins in T7 systems (43). Agglomeration of protein in the cytoplasm might be 
facilitated by the extra Cys residue, resulting in the facile formation of inclusion bodies, 
which cannot be processed. Whatever the problem, the T7 system was abandoned in favor 
of sequential 12L protein preps. This brute force approach, while labor intensive and 
inelegant, did give mature K73C 13-lactamase. 
The 15N experiment was hindered in part by the inherent low sensitivity of ISN 
NMR. It was determined that -70 mgs of protein would be required to see a signal, but 
unfortunately the upper limit of solubility of RTEM-1 13-lactamase is 20 mg/ml. These two 
factors conspired to doom the pKa determination by direct observation of the 15N chemical 
shift change with pH. Repeated attempts to see a signal, using both 5 mm and 10 mm 
probes and accumulation times of up to 24 hours failed to give any ISN signal. 
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It was hoped that the greater sensitivity of Be NMR would overcome the solubility 
problems, and that the Be signal could be seen directly in labeled protein. However, a 
different problem arose. The labeled bromoethylamine hydrobromide was synthesized so 
as to put the Be-carbon in the position ~- to the amine, as this carbon undergoes much 
greater change in chemical shift. Unfortunately, the proposed mechanism of labeling causes 
the Be label to be scramble (Figure 32). Since the actual labeling species is hypothesized 
to be ethyleneimine, there is actually a 50:50 distribution of Be label in the e-1 and e-2 
positions. Therefore, the concentration of label at a given position is cut in half, effectively 
lowering the labeled protein concentration to <10 mg/ml. This amount of labeled protein 
was unfortunately not enough to see in a direct observation Be experiment. 
The only possibility of determining the pKa by NMR was in an HMQC indirect 
observation experiment. The initial experiments involving the Be-2-bromoethylamine 
hydrobromide model compound were encouraging, with excellent editing and resolution 
seen. However studies on the labeled enzyme were not so clean and clear cut. The presence 
of a great number of peaks in the labeled K73AEe ~-lactamase indicated fundamental 
problems with either the sample or the experiment. A control experiment was devised to 
assay not only the NMR parameters, but also the possibility of other residues in the protein 
being modified, thus giving more than one peak. Since two different labeling conditions 
were used in the creation of the 13e-K73AEe, these conditions were duplicated in the 
wild-type control experiment; (1) 500 mM phosphate , pH 8.4, 100 mM Be-2-
bromoethylamine hydrobromide, and 37°; (2) 500 mM phosphate, pH 8.4, 100 mM Be-2-
bromoethylamine hydrobromide, 4 M urea. Interestingly, these two conditions yielded 
protein that showed only one non-artifact peak, but the chemical shifts of the peaks were 
different by -0.3 ppm. The identity of the labeled species, and the reason for the 
differences in chemical shifts is not known. 
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Figure 32. Mechanism of 13C label scrambling during 13-lactamase modification. 
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The results of only one peak being seen in the control experiments were 
encouraging, indicating that the plethora of peaks seen in the K73AEC sample were due to 
impurities that were labeled. The sample was subjected to FPLC purification, and five 
peaks were seen, with the peak containing the ~-lactamase being the largest (data not 
shown). This rechromatographed sample was subjected to another HMQC experiment with 
identical parameters to the other, with the exception of acquisition time, which was much 
greater for the rechromatographed sample. It was very encouraging that one peak rose out 
of the aliphatic region in the 13C-edited spectra. The chemical shift of this broad singlet is -
2.7 ppm (referenced to water). Calculated chemical shifts for the protons in the aminoethyl 
cysteine residue range from -2.8 to 3.45 ppm depending on protonation state of the amine. 
Thus the observed peak could be from the aminoethyl cysteine; the chemical shift is in the 
correct range, and the peak is rather broad, which would be expected for a proton signal 
from a large molecule. It is interesting that only one peak is seen. This could be evidence 
that the actual labeling mechanism follows a SN2 pathway rather than the achiral 
intermediate shown in Figure 32. Unfortunately, the sample had degraded to a point that 
excessive acquisition times were required to see a signal. Therefore, the pH behavior of 
this observed peak could not be assayed. Calculations indicate that both the a- and ~­
protons (relative to the amine) should shift - 0.3 ppm upon protonation of the amine 
(Figure 33). This chemical shift change is well within the observable range under the 
experimental conditions. 
A new sample was generated as above (-15 mg K73AEC ~-lactamase), and was 
labeled under the urea conditions. HMQC NMR analysis did not show any strong peaks, 
but many weak peaks indicative of signals from background Be molecules in the protein. 
The protein was labeled under the 37°C conditions, with the resulting spectra shown in 
Figure 34. Two peaks of interest are seen, one at -3.2 ppm (triplet), and one at -2.3 ppm. 
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Figure 33. Calculated chemical shift values for aminethylcysteine in K73AEC ~-lactamase. 
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Figure 34. Spectra from HMQC NMR experiment on 13C-K73AEC j3-lactamase. 
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peak at 3.2 ppm is from the protons 13- to the amine, which is where the Be label would be 
expected. Also since this spectra is not proton decoupled, a triplet would be expected. The 
identity of the other peak is unknown and deserves further investigation. 
With the observation of a peak at the assumed correct chemical shift, the NMR 
titration experiment was undertaken. NMR spectra were generated at five different pH's; 
6.6, 7.7, 8.5, 9.8, 12.5 (Figures 35-37). The sample was in D20, with 25 mM potassium 
phosphate buffer. pH was adjusted with D3P04 and KOD solutions in D20. The two 
observed peaks did move, with the peak at 3.2 shifting -0.4 ppm, as predicted by 
calculations. The other peak showed a much greater sensitivity to pH, with chemical shift 
varying by -1 ppm. The pKa of the ionizable group adjacent to the observed protons can be 
estimated by plotting the chemical shift change. The amine functionality assumed to be 13- to 
the protons observed in the 3.2 ppm peak (in the aminoethylcysteine residue at position 73) 
has a pKa of -10.5 (Figure 38). This is what would be expected for a typical lysyl amine. 
Thus, it would appear that the amine at position 73 cannot function as a general base. 
However it must be pointed out that this NMR measurement is made on the free enzyme; 
there is no substrate available. It has been suggested that 13-lactamase undergoes a 
significant conformational change upon binding of substrate (14). It could be envisioned 
that this altered protein conformation could induce a lowered pK3 for Lys 73, thus 
deprotonating the amine, making it available to act as a general base in the acylation step of 
the reaction. This hypothesis could be tested by using a double mutant which gives the 
chemical modification abilities at position 73 (K73C), along with acylation deficiency 
(S70A). This mutant should bind substrate, but not be acylated. Thus, the pKa of the 
K73AEC derivative could be assayed as free enzyme, and also in the presence of bound 
substrate. This would indicate whether the conformational changes influence the chemical 
behavior of the active site residues. 
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Figure 37. Spectra from HMQC NMR titration experiments for pH 12.5. 
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Figure 38. Plot of chemical shift vs. pH for first peak seen in HMQC NMR titration 
experiments. 
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The other peak seen also undergoes a chemical shift change with alteration of pH. 
The pKa of the group being ionized which influences the protons being seen is -8 (Figure 
39). The presence of this peak is puzzling. It's chemical shift does not jibe with known or 
calculated chemical shifts for any expected derivatization products. Also, the magnitude of 
the chemical shift change is very large ( -1 ppm). It is perhaps possible that the two signals 
(3.2 ppm and 2.6 ppm) seen are from identical protons, but that the enzyme is has adopted 
two distinct conformations which create markedly different environments for the protons 
observed. It is known that the K73AEC enzyme only has -50% of the activity of wild-
type. It is not known whether this is due to incorrect positioning of the modified enzyme 
catalytic groups, or folding problems encountered upon renaturation following labeling. If 
this peak is in fact from correctly labeled and folded enzyme, then the observed pKa would 
support the hypothesis that Lys 73 functions as a general base, as the pKa is depressed. 
Efforts are underway to investigate the identity of labeled residue(s) in the protein by tryptic 
digest and sequence analysis. Also, further studies using 15N chemical editing experiments 
are planned, which should unequivocally identify the pKa of the amine functionality at 
position 73. 
In spite of the myriad experimental problems encountered, this approach of using 
site-directed mutagenesis in conjunction with chemical modification and NMR to determine 
pKa could be applicable to other system, not only for the determination of acidity 
constants, but also for use in 20 and 3D NMR experiments for structure determination and 
or substrate binding studies. The subtle nature of the -S- for -CH2- substitution [bond 
length 1.54A. (C-C) vs. 1.82A. (C-S); bond angles 109° (C-C-C) vs. 105° (C-S-C)] results 
in only a minor repositioning of the E-NH2 group (44). One especially attractive application 
would be in the field of rational drug design, with active site labeled protein being used to 
analyzed the solution substrate binding of a large variety of small molecule drug analogs. 
Thus a relatively large number of drug candidates could be examined for binding geometry 
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Figure 39. Plot of chemical shift vs. pH for second peak seen in HMQC NMR titration 
experiments. 
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and efficiency by NMR without the requirement of crystallization. All of these applications 
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